705 genotypes with 895 annotations displayed
of selected term and subterms
|
Searched Term: abnormal blood vessel physiology
|
Abca4tm1Ght/Abca4tm1Ght Rdh8tm1Kpal/Rdh8tm1Kpal
(involves: 129 * 129S4/SvJae)
|
choroidal neovascularization
|
J:154536
|
Abcb1atm1Bor/Abcb1atm1Bor
(involves: 129P2/OlaHsd * FVB)
|
impaired blood-brain barrier function
|
J:18554
|
Abcb1atm1Bor/Abcb1atm1Bor
(FVBTac.129P2-Abcb1atm1Bor)
|
abnormal blood-inner ear barrier function
|
J:59145
|
Abcc4tm1Jsch/Abcc4tm1Jsch
(involves: 129X1/SvJ)
|
abnormal blood-brain barrier function
|
J:92788
|
abnormal blood-cerebrospinal fluid barrier function
|
J:92788
|
Abcc4tm1Kruh/Abcc4tm1Kruh
(B6.129-Abcc4tm1Kruh)
|
abnormal blood-brain barrier function
|
J:117326
|
Abcc9em1Nich/Abcc9+
(involves: C57BL/6J * CBA/J)
|
abnormal blood vessel physiology
|
J:281903
|
abnormal vascular smooth muscle physiology
|
J:281903
|
increased vasodilation
|
J:281903
|
Abcc9em1Nich/Abcc9em1Nich
(involves: C57BL/6J * CBA/J)
|
abnormal vascular smooth muscle physiology
|
J:281903
|
Abcc9tm1Cfb/Abcc9tm1Cfb
(Not Specified)
|
abnormal vascular smooth muscle physiology
|
J:78066
|
coronary artery spasm
|
J:78066
|
Abhd2Gt(pUHachi)8025Imeg/Abhd2Gt(pUHachi)8025Imeg
(involves: C57BL/6NCrj * CBA/JNCrj)
|
abnormal vascular wound healing
|
J:96209
|
Ace2tm1Cof/Ace2tm1Cof
(involves: 129S6/SvEvTac * C57BL/6)
|
cornea vascularization
|
J:289503
|
Ace2tm1Pngr/Y
(involves: 129P2/OlaHsd)
|
increased vascular permeability
|
J:100334
|
Ace2tm1Pngr/Ace2tm1Pngr
(involves: 129P2/OlaHsd)
|
increased vascular permeability
|
J:100334
|
Acta2tm1Rjs/Acta2tm1Rjs
(involves: 129S7/SvEvBrd * C57)
|
decreased vasoconstriction
|
J:113261
|
Acta2tm1Rjs/Acta2tm1Rjs
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased vascular permeability
|
J:111893
|
Acvrl1tm1Dyl/Acvrl1tm1Dyl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased vasodilation
|
J:85366
|
Acvrl1tm1Enl/Acvrl1+
(involves: C57BL/6)
|
telangiectasia
|
J:82115
|
Acvrl1tm2.1Spo/Acvrl1tm2.1Spo Tg(Tal1-cre/ERT)1Jrg/0
(involves: 129 * C57BL/6)
|
abnormal vascular wound healing
|
J:227170
|
Adatm1Mw/Adatm1Mw
(involves: 129S7/SvEvBrd)
|
increased vascular smooth muscle cell proliferation
|
J:231559
|
Adam9tm1Bbl/Adam9tm1Bbl
(involves: 129)
|
abnormal induced retina neovascularization
|
J:148993
|
Adam15tm1Bbl/Adam15tm1Bbl
(129X1/SvJ-Adam15tm1Bbl)
|
abnormal induced retina neovascularization
|
J:84800
|
Adam15tm1Bbl/Adam15tm1Bbl
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal induced retina neovascularization
|
J:217858,
J:84800
|
Adam15tm1Bbl/Adam15tm1Bbl
(B6.129X1-Adam15tm1Bbl)
|
abnormal induced retina neovascularization
|
J:84800
|
Adam15tm1Dgen/Adam15tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal induced retina neovascularization
|
J:138010
|
decreased susceptibility to induced choroidal neovascularization
|
J:138010
|
Adam15tm1Dgen/Adam15tm1Dgen Tg(RHO-VEGFA)V-6Camp/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal induced retina neovascularization
|
J:138010
|
Adam17woe/Adam17woe
(C57BL/6-Adam17woe)
|
pathological neovascularization
|
J:160781
|
Adamts7tm1a(KOMP)Wtsi/Adamts7tm1a(KOMP)Wtsi
(involves: C57BL/6N)
|
abnormal vascular wound healing
|
J:230573
|
decreased vascular endothelial cell proliferation
|
J:230573
|
Adgra2tm1.2Bstc/Adgra2tm1.2Bstc
(B6.Cg-Adgra2tm1.2Bstc)
|
abnormal blood-cerebrospinal fluid barrier function
|
J:171226
|
impaired blood-brain barrier function
|
J:171226
|
Adipoqtm1Chan/Adipoq+
(B6.129-Adipoqtm1Chan)
|
increased vascular endothelial cell adhesion
|
J:122020
|
Adipoqtm1Chan/Adipoqtm1Chan
(B6.129-Adipoqtm1Chan)
|
increased vascular endothelial cell adhesion
|
J:122020
|
Adipoqtm1Ish/Adipoqtm1Ish
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal vascular wound healing
|
J:79350
|
abnormal vasodilation
|
J:103106
|
Adipoqtm1Tka/Adipoqtm1Tka
(involves: 129S4/SvJae * C57BL/6)
|
abnormal vascular wound healing
|
J:77876
|
Adm2em1Zhan/Adm2em1Zhan
(Not Specified)
|
increased vascular permeability
|
J:266495
|
Admtm1Tfjt/Adm+
(involves: C57BL/6 * CBA)
|
blood vessel inflammation
|
J:102946
|
Adora2btm1Dgen/Adora2btm1Dgen
(B6.129P2-Adora2btm1Dgen)
|
increased vascular permeability
|
J:131314
|
Adra1atm1Pcs/Adra1atm1Pcs
(involves: 129X1/SvJ * FVB/N)
|
decreased vasoconstriction
|
J:77732
|
Adra1btm1Cta/Adra1btm1Cta
(involves: 129P2/OlaHsd)
|
decreased vasoconstriction
|
J:103581
|
Adra2btm1Gsb/Adra2btm1Gsb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal vasoconstriction
|
J:34819
|
Afg1lem1(IMPC)Kmpc/Afg1lem1(IMPC)Kmpc
(C57BL/6NTac-Afg1lem1(IMPC)Kmpc/Kmpc)
|
cornea vascularization
|
J:211773
|
Agertm1.1Arnd/Agertm1.1Arnd
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:82620
|
abnormal vascular wound healing
|
J:82620
|
decreased vascular smooth muscle cell proliferation
|
J:82620
|
Aggf1Gt(PT036)Byg/Aggf1+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal vascular endothelial cell physiology
|
J:239252
|
increased vascular permeability
|
J:239252
|
Aggf1tm1Qkw/Aggf1+
(involves: 129 * C57BL/6)
|
abnormal vascular endothelial cell physiology
|
J:239252
|
increased vascular permeability
|
J:239252
|
Agttm1Afu/Agttm1Afu
(involves: C57BL/6 * CBA)
|
impaired blood-brain barrier function
|
J:59299
|
Agtr2tm1Gsb/Y
(FVB.129-Agtr2tm1Gsb)
|
abnormal vasoconstriction
|
J:103237
|
increased vasoconstriction
|
J:103376
|
Agxt2tm1Lex/Agxt2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased vasodilation
|
J:207876
|
Ahcyem1Cya/Ahcy+
(C57BL/6N-Ahcyem1Cya/Cya)
|
abnormal vasodilation
|
J:298071
|
Amotl2em1(IMPC)Mbp/Amotl2em1(IMPC)Mbp
(C57BL/6NCrl-Amotl2em1(IMPC)Mbp/MbpMmucd)
|
cornea vascularization
|
J:211773
|
Angpt1tm1.1Seq/Angpt1tm1.1Seq Angpt2tm1c(KOMP)Seq/Angpt2tm1c(KOMP)Seq Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/? Tg(tetO-cre)1Jaw/0
(involves: 129 * C57BL/6NCr)
|
cornea vascularization
|
J:217296
|
Angpt1tm1.1Yona/Angpt1tm1.1Yona Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(involves: 129S4/SvJae)
|
increased vascular permeability
|
J:213456
|
Angpt2tm1Gdy/Angpt2tm1Gdy
(involves: 129P2/OlaHsd * C57BL/6)
|
retina neovascularization
|
J:89618
|
Angptl4tm1Vlcg/Angptl4tm1Vlcg
(Not Specified)
|
abnormal induced retina neovascularization
|
J:177790
|
increased vascular permeability
|
J:177790
|
Ankrd17tm1.1Yty/Ankrd17tm1.1Yty
(B6.129P2-Ankrd17tm1.1Yty)
|
increased vascular permeability
|
J:152840
|
Ano1tm1.1Cahb/Ano1tm1.1Cahb Tg(Myh11-icre/ERT2)1Soff/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
abnormal blood vessel physiology
|
J:207993
|
decreased vasoconstriction
|
J:207993
|
Anpeptm1Sid/Anpep+
(involves: 129S/SvEv * C57BL/6)
|
retina neovascularization
|
J:119474
|
Anpeptm1Sid/Anpeptm1Sid
(involves: 129S/SvEv * C57BL/6)
|
pathological neovascularization
|
J:119474
|
retina neovascularization
|
J:119474
|
Anxa1tm1Rjf/Anxa1tm1Rjf
(involves: 129 * C57BL/6)
|
abnormal vascular endothelial cell physiology
|
J:153690
|
decreased vascular endothelial cell proliferation
|
J:153690
|
Ap1g1fgt/Ap1g1fgt
(C57BL/6-Ap1g1fgt/KjnBoc)
|
choroidal neovascularization
|
J:230572
|
Apex1tm1Cur/Apex1+
(involves: 129S1/Sv)
|
abnormal vascular smooth muscle physiology
|
J:119957
|
abnormal vascular wound healing
|
J:119957
|
decreased vasoconstriction
|
J:102294
|
decreased vasodilation
|
J:102294
|
increased vasoconstriction
|
J:102294
|
Apoa1tm1Unc/Apoa1tm1Unc
(B6.129P2-Apoa1tm1Unc/J)
|
abnormal vascular wound healing
|
J:118063
|
Apobtm2Sgy/Apobtm2Sgy Ldlrtm1Her/Ldlrtm1Her Tg(Ins-Igf2)1Fbos/?
(involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6J * SJL)
|
aortitis
|
J:227165
|
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc/J)
|
abnormal blood vessel physiology
|
J:60364
|
abnormal vascular smooth muscle physiology
|
J:338121
|
abnormal vasodilation
|
J:298071
|
blood vessel inflammation
|
J:91058
|
decreased vasodilation
|
J:101576
|
impaired blood-brain barrier function
|
J:69455
|
Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd)
|
decreased vasodilation
|
J:154332
|
Apoetm1Unc/Apoetm1Unc Cdkn1atm1Tyj/Cdkn1atm1Tyj
(B6.129-Apoetm1Unc Cdkn1atm1Tyj)
|
abnormal vascular smooth muscle physiology
|
J:125247
|
increased vascular smooth muscle cell proliferation
|
J:125247
|
Apoetm1Unc/Apoetm1Unc Faslgld/Faslgld
(B6.Cg-Faslgld Apoetm1Unc)
|
blood vessel inflammation
|
J:91058
|
Apoetm1Unc/Apoetm1Unc Il1r1tm1Imx/Il1r1tm1Imx
(B6.129-Il1r1tm1Imx Apoetm1Unc)
|
abnormal blood vessel physiology
|
J:148173
|
increased vasoconstriction
|
J:148173
|
increased vasodilation
|
J:148173
|
Apoetm1Unc/Apoetm1Unc Klf15tm2Jain/Klf15tm2Jain Tg(Tagln-cre)1Jjl/0
(involves: 129P2/OlaHsd * FVB/N)
|
blood vessel inflammation
|
J:203920
|
Apoetm1Unc/Apoetm1Unc Lpltm1Sem/Lpltm1Sem
(involves: 129P2/OlaHsd)
|
abnormal vascular wound healing
|
J:151434
|
Apoetm1Unc/Apoetm1Unc Sprr3tm1.1Ppy/Sprr3tm1.1Ppy
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J * SJL)
|
abnormal vascular smooth muscle physiology
|
J:230470
|
Apoetm1Unc/Apoetm1Unc Timp1tm1Pds/Y
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal blood vessel physiology
|
J:103082
|
Apoetm3(APOE*4)Mae/Apoetm3(APOE*4)Mae
(involves: 129P2/OlaHsd * C57BL/6)
|
retina neovascularization
|
J:101147
|
Appl1tm1Ymli/Appl1tm1Ymli
(involves: 129S1/Sv * C57BL/6J)
|
decreased vasodilation
|
J:189487
|
increased vasoconstriction
|
J:189487
|
Aqp1tm1Ask/Aqp1tm1Ask
(involves: C57BL/6J * CD-1)
|
decreased vascular permeability
|
J:106259
|
Aqp1tm1Ask/Aqp1tm1Ask Aqp4tm1Ask/Aqp4tm1Ask
(involves: C57BL/6J * CD-1)
|
decreased vascular permeability
|
J:106259
|
Aqp4tm1.1Geno/Aqp4tm1.1Geno Tg(GFAP-cre)25Mes/0
(involves: C57BL/6J * FVB/N)
|
abnormal blood-brain barrier function
|
J:177412
|
Aqp4tm1.1Lmno/Aqp4tm1.1Lmno
(B6.Cg-Aqp4tm1.1Lmno)
|
abnormal blood-brain barrier function
|
J:177412
|
Arhgap42Gt(CE0477)Wtsi/Arhgap42Gt(CE0477)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
increased vasoconstriction
|
J:221301
|
Arhgef1tm1Rmt/Arhgef1tm1Rmt X/Tg(Myh11-icre/ERT2)1Soff
(involves: C57BL/6 * FVB/N)
|
decreased vasoconstriction
|
J:157074
|
Arhgef4tm1Taki/Arhgef4tm1Taki
(involves: C57BL/6 * C57BL/6J * CBA)
|
abnormal vascular endothelial cell physiology
|
J:159959
|
Arhgef12tm1Soff/Arhgef12tm1Soff
(Not Specified)
|
decreased vasoconstriction
|
J:141641
|
Arhgef26tm1.1Kbur/Arhgef26tm1.1Kbur
(B6.Cg-Arhgef26tm1.1Kbur)
|
abnormal vascular endothelial cell physiology
|
J:195919
|
Asic2tm1Wsh/Asic2+
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal blood vessel physiology
|
J:135644
|
decreased vasoconstriction
|
J:135644
|
Asic2tm1Wsh/Asic2tm1Wsh
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased vasoconstriction
|
J:135644
|
Asltm1Brle/Asltm1Brle
(involves: 129S7/SvEvBrd)
|
decreased vasodilation
|
J:180208
|
Atictm1c(EUCOMM)Hmgu/Atictm1c(EUCOMM)Hmgu Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6J * C57BL/6N)
|
abnormal vascular wound healing
|
J:338121
|
decreased vascular smooth muscle cell proliferation
|
J:338121
|
Atictm1c(EUCOMM)Hmgu/Atictm1c(EUCOMM)Hmgu X/Tg(Myh11-icre/ERT2)1Soff
(involves: 129S4/SvJaeSor * C57BL/6J * C57BL/6N * FVB/N)
|
abnormal vascular wound healing
|
J:338121
|
decreased vascular smooth muscle cell proliferation
|
J:338121
|
Atp2a2tm1.1Raco/Atp2a2+
(C57BL/6J-Atp2a2tm1.1Raco/Raco)
|
abnormal vascular endothelial cell physiology
|
J:216004
|
Atp2a3tm1Ges/Atp2a3tm1Ges
(involves: Black Swiss)
|
abnormal vascular endothelial cell physiology
|
J:44333
|
Atp2b1tm1.1Hiraw/Atp2b1tm1.1Hiraw Tg(Tagln-cre)1Her/0
(B6J.Cg-Atp2b1tm1.1Hiraw Tg(Tagln-cre)1Her)
|
increased vasoconstriction
|
J:225010
|
Atp2b1tm1Ges/Atp2b1+ Atp2b4tm1Ges/Atp2b4tm1Ges
(Black Swiss)
|
decreased vasoconstriction
|
J:91844
|
Atp2b4tm1Ges/Atp2b4tm1Ges
(involves: 129X1/SvJ * Black Swiss)
|
decreased vasoconstriction
|
J:91844
|
Avpr1atm1Gzt/Avpr1atm1Gzt
(involves: 129 * C57BL/6J)
|
abnormal vasoconstriction
|
J:110099
|
Awat2tm1.2Golc/Y
(involves: 129 * C57BL/6 * C57BL/6J)
|
conjunctival telangiectasia
|
J:308387
|
cornea vascularization
|
J:308387
|
Awat2tm1.2Golc/Awat2tm1.2Golc
(involves: 129 * C57BL/6 * C57BL/6J)
|
conjunctival telangiectasia
|
J:308387
|
cornea vascularization
|
J:308387
|
Axltm1Grl/Axltm1Grl
(involves: C57BL/6J)
|
increased vascular permeability
|
J:198769
|
Barx2tm1b(EUCOMM)Hmgu/Barx2tm1b(EUCOMM)Hmgu
(C57BL/6N-Barx2tm1b(EUCOMM)Hmgu/H)
|
cornea vascularization
|
J:211773
|
Bcar1tm1Hhi/Bcar1tm1Hhi
(involves: 129S/SvEv * C57BL/6)
|
increased vasodilation
|
J:48967
|
Bcl2tm1Sjk/Bcl2tm1Sjk
(involves: 129S2/SvPas * C57BL/6)
|
abnormal induced retina neovascularization
|
J:96232
|
Best3tm1.1Zhoj/Best3tm1.1Zhoj Tg(Tagln-cre)1Her/0
(involves: C57BL/6 * SJL)
|
abnormal vascular smooth muscle physiology
|
J:338981
|
aortitis
|
J:338981
|
Bld/Bld+
(involves: BALB/cCi)
|
cornea vascularization
|
J:5076
|
Bmal1tm1Bra/Bmal1tm1Bra
(B6.129-Bmal1tm1Bra)
|
abnormal vascular smooth muscle physiology
|
J:191844
|
cornea vascularization
|
J:110697
|
decreased vasodilation
|
J:191844
|
increased vasoconstriction
|
J:191844
|
Bmp4tm2Blh/Bmp4+
(involves: 129S6/SvEvTac * ICR)
|
abnormal vascular endothelial cell physiology
|
J:112335
|
Bmpertm1Cpat/Bmper+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal induced retina neovascularization
|
J:191849
|
Bmpr2tm1.1Enl/Bmpr2tm1.1Enl Tg(Acvrl1-cre)L1Spo/0
(involves: 129S4/SvJae * FVB)
|
increased vascular smooth muscle cell proliferation
|
J:158116
|
Bmpr2tm1Kmi/Bmpr2+
(involves: 129S4/SvJae * C57BL/6J)
|
increased vasoconstriction
|
J:117167
|
Bmpr2tm1Mmue/Bmpr2+
(B6.129S1-Bmpr2tm1Mmue)
|
increased vascular permeability
|
J:224752
|
C1qtnf5tm1.1Itl/C1qtnf5+
(C57BL/6-C1qtnf5tm1.1Itl)
|
increased vascular permeability
|
J:171089
|
C3tm1Crr/C3tm1Crr
(involves: 129S4/SvJae * C57BL/6)
|
decreased vascular permeability
|
J:78613
|
C4btm1Crr/C4btm1Crr
(involves: 129S4/SvJae * C57BL/6)
|
decreased vascular permeability
|
J:78613
|
Cacna1htm1Kcam/Cacna1htm1Kcam
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased vasoconstriction
|
J:86616
|
Cacnb3tm1Acv/Cacnb3tm1Acv
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vascular smooth muscle physiology
|
J:86381
|
Cav1tm1Kur/Cav1tm1Kur
(involves: 129X1/SvJ * C57BL/6)
|
abnormal vasoconstriction
|
J:71760
|
increased vasodilation
|
J:71760
|
Cav1tm1Mls/Cav1tm1Mls
(involves: 129/Sv * C57BL/6 * SJL)
|
abnormal vasoconstriction
|
J:75193
|
abnormal vasodilation
|
J:75193
|
Cav1tm1Mls/Cav1tm1Mls
(involves: 129/Sv * C57BL/6J * SJL)
|
abnormal vascular wound healing
|
J:115492
|
decreased vasoconstriction
|
J:120603
|
increased vascular permeability
|
J:79595
|
Cav1tm1Mls/Cav1tm1Mls
(STOCK Cav1tm1Mls/J)
|
decreased vasoconstriction
|
J:132392
|
increased vasodilation
|
J:132392
|
Cav1tm1Mls/Cav1tm1Mls
(B6.Cg-Cav1tm1Mls/J)
|
increased vascular permeability
|
J:143600
|
Cbstm1Unc/Cbs+
(B6.129P2-Cbstm1Unc/J)
|
abnormal vascular endothelial cell physiology
|
J:64885
|
abnormal vasodilation
|
J:64885
|
increased vascular permeability
|
J:213631
|
retina neovascularization
|
J:213631
|
Ccl2tm1Rol/Ccl2tm1Rol
(involves: 129S4/SvJae)
|
increased vasodilation
|
J:155025
|
Ccl2tm1Rol/Ccl2tm1Rol
(B6.129S4-Ccl2tm1Rol)
|
choroidal neovascularization
|
J:147328
|
Ccl2tm1Rol/Ccl2tm1Rol Cx3cr1tm1Zm/Cx3cr1tm1Zm
(involves: 129 * 129S4/SvJae)
|
choroidal neovascularization
|
J:126935
|
Ccm2tm2.1Sbn/Ccm2tm2.1Sbn Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
impaired blood-brain barrier function
|
J:174085
|
Ccn3tm1Hko/Ccn3tm1Hko
(B6.129-Ccn3tm1Hko)
|
abnormal vascular wound healing
|
J:172144
|
increased vascular smooth muscle cell proliferation
|
J:172144
|
Ccr2tm1Ifc/Ccr2tm1Ifc
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal vascular wound healing
|
J:110790
|
Ccr2tm1Mae/Ccr2tm1Mae
(B6.129P2-Ccr2tm1Mae)
|
choroidal neovascularization
|
J:147328
|
Ccr5tm1Kuz/Ccr5tm1Kuz
(B6.129P2-Ccr5tm1Kuz)
|
cornea vascularization
|
J:118018
|
Cd1tm1Gru/Cd1tm1Gru
(B6.129S2-Cd1tm1Gru)
|
decreased susceptibility to induced choroidal neovascularization
|
J:138197
|
Cd19tm1(cre)Cgn/Cd19+ Ep300tm2Reck/Ep300+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
arteritis
|
J:147840
|
Cd44tm1Hbg/Cd44tm1Hbg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
choroidal neovascularization
|
J:154560
|
Cd44tm1Mak/Cd44tm1Mak
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal vascular smooth muscle physiology
|
J:101783
|
Cd44tm1Mak/Cd44tm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal vascular endothelial cell physiology
|
J:110162
|
Cd46tm1Atk/Cd46tm1Atk
(B6.129-Cd46tm1Atk)
|
increased susceptibility to induced choroid neovascularization
|
J:213630
|
Cd59atm1Bpm/Cd59atm1Bpm
(B6.129-Cd59atm1Bpm)
|
choroidal neovascularization
|
J:143638
|
Cd82tm1.1Xaz/Cd82tm1.1Xaz
(B6NCr.Cg-Cd82tm1.1Xaz)
|
abnormal induced retina neovascularization
|
J:234155
|
Cd151tm1Mhe/Cd151tm1Mhe
(B6.129S-Cd151tm1Mhe)
|
abnormal vascular endothelial cell physiology
|
J:141595
|
Cd180tm1Kmiy/Cd180tm1Kmiy Faslpr/Faslpr
(MRL.Cg-Cd180tm1Kmiy Faslpr)
|
blood vessel inflammation
|
J:137066
|
Cdh5tm1.1Ics/Cdh5tm1.1Ics
(B6.129(Cg)-Cdh5tm1.1Ics)
|
increased vascular permeability
|
J:214298
|
Cdh5tm3(Cdh5/Ctnna1)Dvst/Cdh5tm3(Cdh5/Ctnna1)Dvst
(involves: 129 * C57BL/6)
|
abnormal vascular permeability
|
J:177191
|
Cdh5tm4(Cdh5/Fkbp,Ptprb/Mtor*)Dvst/Cdh5tm4(Cdh5/Fkbp,Ptprb/Mtor*)Dvst
(involves: C57BL/6)
|
decreased vascular permeability
|
J:178759
|
Cdh13tm1Brns/Cdh13tm1Brns
(involves: 129)
|
retina neovascularization
|
J:132759
|
Ceacam1tm1Geno/Ceacam1tm1Geno
(B6.129-Ceacam1tm1Geno)
|
abnormal vascular wound healing
|
J:207881
|
Chd2Gt(RRBO46)Byg/Chd2+
(involves: 129P2/OlaHsd * C57BL/6)
|
arteritis
|
J:146176
|
Chrdtm1Emdr/Chrdtm1Emdr
(either: B6SJL.129-Chrdtm1Emdr or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL/J))
|
increased vasodilation
|
J:83662
|
Chrm3tm1Jwe/Chrm3tm1Jwe
(involves: 129S6/SvEvTac * CF-1)
|
decreased vasodilation
|
J:102321
|
Chrm5tm1Jwe/Chrm5tm1Jwe
(involves: 129S6/SvEvTac * CF-1)
|
abnormal vasodilation
|
J:72953
|
Cisd2tm1Tfts/Cisd2tm1Tfts
(B6.129S7-Cisd2tm1Tfts)
|
retina neovascularization
|
J:148467
|
Clcn2tm1Tjj/Clcn2tm1Tjj
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
impaired blood-brain barrier function
|
J:122365
|
Cldn5tm1Sts/Cldn5tm1Sts
(involves: 129S4/SvJae * C57BL/6)
|
impaired blood-brain barrier function
|
J:83341
|
Clic4tm1Jce/Clic4tm1Jce
(involves: 129S1/Sv * CD-1)
|
abnormal vascular endothelial cell physiology
|
J:146487
|
Col3a1m1Lsmi/Col3a1+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased vasoconstriction
|
J:180733
|
Col4a1ENU911/Col4a1+
(C3.Cg-Col4a1ENU911)
|
cornea vascularization
|
J:163225
|
Comptm1Aol/Comptm1Aol
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vascular wound healing
|
J:230573
|
Cptm1Hrs/Cptm1Hrs Hephsla/Y
(involves: 129X1/SvJ * C57BL/6)
|
retina neovascularization
|
J:92620,
J:136925
|
Cpt1atm1.1Pec/Cpt1atm1.1Pec Tg(Cdh5-cre/ERT2)1Rha/0
(Not Specified)
|
decreased vascular endothelial cell proliferation
|
J:220527
|
Crb1em2Boc/Crb1em2Boc Jak3m1J/Jak3m1J
(B6.Cg-Crb1em2Boc Jak3m1J/Boc)
|
retina neovascularization
|
J:353326
|
Crb1rd8/Crb1rd8
(B6.Cg-Crb1rd8 Jak3+/Boc)
|
retina neovascularization
|
J:265859
|
Crb1rd8/Crb1rd8 Jak3m1J/Jak3m1J
(B6.Cg-Crb1rd8 Jak3m1J/BocJ)
|
retina neovascularization
|
J:265859
|
Crb1rd8/Crb1rd8 rnv5/rnv5+
(B6N.Cg-rnv5/BocJ)
|
retina neovascularization
|
J:352529
|
Crb2tm1.1Wij/Crb2tm1.1Wij Tg(Crx-cre)1Tfur/0
(involves: 129P2/OlaHsd * C57BL/6J)
|
retina neovascularization
|
J:210675
|
Crhr2tm1Jsp/Crhr2tm1Jsp
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal vascular permeability
|
J:61485
|
Crim1em1(IMPC)Wtsi/Crim1em1(IMPC)Wtsi
(C57BL/6N-Crim1em1(IMPC)Wtsi/WtsiOrl)
|
telangiectasia
|
J:239583
|
Crim1Gt(KST264)Byg/Crim1Gt(KST264)Byg
(involves: 129P2/OlaHsd * C57BL/6 * CD-1)
|
increased vascular permeability
|
J:172334
|
Crktm1.1Cur/Crktm1.1Cur
(involves: 129S/SvEv * C57BL/6)
|
increased vasodilation
|
J:111399
|
Crotem1Akw/Crotem1Akw Ldlrtm1Her/Ldlrtm1Her
(B6.Cg-Crotem1Akw Ldlrtm1Her)
|
blood vessel inflammation
|
J:331161
|
Cry1tm1Asn/Cry1tm1Asn Cry2tm1Hnos/Cry2tm1Hnos
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal vasoconstriction
|
J:134129
|
Csrp1tm1Mbk/Csrp1tm1Mbk
(B6.129-Csrp1tm1Mbk)
|
abnormal vascular wound healing
|
J:172149
|
Csrp2tm1Sfy/Csrp2tm1Sfy
(B6.129S2-Csrp2tm1Sfy)
|
abnormal vascular smooth muscle physiology
|
J:117557
|
abnormal vascular wound healing
|
J:117557
|
Csrp2tm1Sfy/Csrp2tm1Sfy
(involves: 129S2/SvPas)
|
abnormal vascular wound healing
|
J:172149
|
Cthtm1Liwu/Cthtm1Liwu
(involves: 129S/SvEvBrd * C57BL/6J)
|
decreased vasodilation
|
J:140705
|
Ctnna1tm1Efu/Ctnna1tm1Efu Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/Gt(ROSA)26Sor+ Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/0
(involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * C57BL/6NCrl * CBA)
|
impaired blood-brain barrier function
|
J:328283
|
Ctnnb1tm2Kem/Ctnnb1tm2.1Kem Kdrtm1(cre)Sato/Kdr+
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal blood-brain barrier function
|
J:142352
|
Ctsstm1Hap/Ctsstm1Hap
(B6.129S2-Ctsstm1Hap)
|
abnormal vascular endothelial cell physiology
|
J:109410
|
Cttntm1.2Dvst/Cttntm1.2Dvst
(either: B6.Cg-Cttntm1.2Dvst or (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA/2 * SJL))
|
abnormal vascular endothelial cell physiology
|
J:177602
|
increased vascular permeability
|
J:177602
|
Cul3tm1.1Arte/Cul3+
(involves: C57BL/6J * C57BL/6N)
|
abnormal blood vessel physiology
|
J:229424
|
increased vasoconstriction
|
J:229424
|
Cx3cr1tm1Litt/Cx3cr1tm1Litt
(involves: 129P2/OlaHsd * C57BL/6)
|
choroidal neovascularization
|
J:127548
|
Cx3cr1tm1Litt/Cx3cr1tm1Litt
(B6.129P2-Cx3cr1tm1Litt)
|
abnormal vascular wound healing
|
J:124722
|
decreased vascular smooth muscle cell proliferation
|
J:124722
|
Cx3cr1tm1Zm/Cx3cr1tm1Zm
(involves: 129 * C57BL/6)
|
choroidal neovascularization
|
J:127548
|
Cxcr2tm1Mwm/Cxcr2tm1Mwm
(C.129S2(B6)-Cxcr2tm1Mwm/J)
|
cornea vascularization
|
J:87365
|
Cyb5r3tm1c(KOMP)Wtsi/Cyb5r3tm1c(KOMP)Wtsi Tg(Myh11-icre/ERT2)1Soff/0
(B6.Cg-Cyb5r3tm1c(KOMP)Wtsi Tg(Myh11-icre/ERT2)1Soff)
|
decreased vasodilation
|
J:280543
|
increased vasoconstriction
|
J:280543
|
increased vasodilation
|
J:280543
|
Cyp2j5tm1Dcz/Cyp2j5tm1Dcz
(129S/SvEv-Cyp2j5tm1Dcz)
|
increased vasoconstriction
|
J:146047
|
Cysltr1tm1Ykn/Cysltr1tm1Ykn
(involves: C57BL/6)
|
decreased vascular permeability
|
J:77087
|
Ddah1tm1Pval/Ddah1+
(involves: 129X1/SvJ * C57BL/6)
|
abnormal vasodilation
|
J:121719
|
increased vasoconstriction
|
J:121719
|
Ddah1tm1Yjch/Ddah1tm1Yjch Tg(Tek-cre)12Flv/0
(involves: 129S1/Sv * C57BL/6J)
|
abnormal vascular smooth muscle physiology
|
J:168130
|
Del(4C4-C5)1Lap/Del(4C4-C5)1Lap
(involves: 129S6/SvEvTac)
|
abnormal vascular smooth muscle physiology
|
J:158126
|
increased vascular smooth muscle cell proliferation
|
J:158126
|
Del(4Cyp2j13-Cyp2j5)1Brs/Del(4Cyp2j13-Cyp2j5)1Brs
(involves: C57BL/6)
|
abnormal vasoconstriction
|
J:223128
|
Del(5Gtf2i-Limk1)1Uta/Del(5Limk1-Trim50)2Uta
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal blood vessel physiology
|
J:182796
|
Del(5Limk1-Trim50)2Uta/+
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal blood vessel physiology
|
J:182796
|
Dhfrorana/Dhfr+
(involves: C57BL/6JAnu)
|
decreased vasodilation
|
J:236197
|
Dicer1tm1Bdh/Dicer1tm1Bdh Foxp3tm4(YFP/icre)Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ)
|
blood vessel inflammation
|
J:138683
|
Dicer1tm1Bdh/Dicer1tm1Bdh Foxp3tm4(YFP/icre)Ayr/Foxp3tm4(YFP/icre)Ayr
(involves: 129S1/Sv * 129X1/SvJ)
|
blood vessel inflammation
|
J:138683
|
Dll4tm1Nwg/Dll4+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)
|
abnormal induced retina neovascularization
|
J:177797
|
Dll4tm2.1Vlcg/Dll4+ Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6NTac)
|
abnormal induced retina neovascularization
|
J:177797
|
Dpp4tm1.1(DPP4)Pbmj/Dpp4tm1.1(DPP4)Pbmj
(involves: C57BL/6 * C57BL/6NTac)
|
increased vascular permeability
|
J:242025
|
Droshatm1Litt/Droshatm1.1Litt Foxp3tm4(YFP/icre)Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
blood vessel inflammation
|
J:138683
|
Droshatm1Litt/Droshatm1.1Litt Foxp3tm4(YFP/icre)Ayr/Foxp3tm4(YFP/icre)Ayr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
blood vessel inflammation
|
J:138683
|
Dsc2tm1e(KOMP)Wtsi/Dsc2tm1e(KOMP)Wtsi
(C57BL/6N-Dsc2tm1e(KOMP)Wtsi/Wtsi)
|
cornea vascularization
|
J:211773
|
Dstncorn1/Dstncorn1
(A.BY-H2bc H2-T18f/SnJ)
|
cornea vascularization
|
J:31798,
J:98465,
J:114973
|
Dstncorn1/Dstncorn1
(involves: A/WySn * brachy stock * C57BL/6JSmn)
|
cornea vascularization
|
J:83125
|
Dstncorn1/Dstncorn1 Cxcr2tm1Mwm/Cxcr2tm1Mwm
(involves: 129S2/SvPas * A/WySn * BALB/c * brachy stock)
|
cornea vascularization
|
J:139239
|
Ece1tm1Reh/Ece1tm1Reh
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal vasodilation
|
J:46640
|
Ecscrtm1Iked/Ecscrtm1Iked
(Not Specified)
|
decreased vascular endothelial cell apoptosis
|
J:173348
|
pathological neovascularization
|
J:173348
|
EdaTa-6J/Y
(C57BL/6J Aw-J-EdaTa-6J/J)
|
cornea vascularization
|
J:99510
|
Edil3Tg(Sox2-cre)1Amc/Edil3+ Wnt7atm1Amc/Wnt7atm1Amc Wnt7btm1Parr/Wnt7btm2Amc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal blood-brain barrier function
|
J:142352
|
Ednrbtm1.1Yko/Ednrbtm1.1Yko
(involves: 129P2/OlaHsd * Bkl:BKW * C57BL/6 * SJL)
|
decreased vasodilation
|
J:135711
|
Ednrbtm1Yko/Ednrbtm1Yko Tg(Tek-cre)1Ywa/0
(involves: 129P2/OlaHsd * Bkl:BKW * C57BL/6 * SJL)
|
decreased vasodilation
|
J:135711
|
Efemp2tm1.1Hiya/Efemp2tm1.2Hiya Tg(Tagln-cre)1Her/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal blood vessel physiology
|
J:213282
|
Efemp2tm1.1Tynk/Efemp2tm1.1Tynk Tg(Tagln-cre)1Her/0
(involves: C57BL/6 * SJL)
|
abnormal blood vessel physiology
|
J:154659
|
Efemp2tm1.1Tynk/Efemp2tm1.2Tynk Tg(Tagln-cre)1Her/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
abnormal blood vessel physiology
|
J:154659
|
Efemp2tm1.2Hiya/Efemp2tm1.2Hiya
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal vascular smooth muscle physiology
|
J:170883
|
increased vascular endothelial cell apoptosis
|
J:170883
|
increased vascular endothelial cell proliferation
|
J:170883
|
increased vascular smooth muscle cell proliferation
|
J:170883
|
Egfrwa2/Egfrwa2 Sos1tm1Dlb/Sos1+
(involves: 129S1/Sv * 129X1/SvJ * B6EiC3Sn-a/A-Egfrwa2 Wnt3avt)
|
cornea vascularization
|
J:38321
|
Egr1tm1Jmi/Egr1tm1Jmi
(involves: 129)
|
abnormal vascular wound healing
|
J:61294
|
Elk3tm1Wlyk/Elk3tm1Wlyk
(either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6))
|
abnormal blood vessel physiology
|
J:71816
|
Elntm1Dyl/Eln+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal blood vessel physiology
|
J:51109
|
Elntm1Dyl/Eln+
(B6.129-Elntm1Dyl)
|
abnormal blood vessel physiology
|
J:86535
|
Elntm1Dyl/Eln+
(involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal blood vessel physiology
|
J:96831
|
abnormal vascular wound healing
|
J:96831
|
Engtm1Mle/Eng+
(involves: 129P2/OlaHsd * C57BL/6)
|
ear telangiectasia
|
J:58502
|
neck telangiectasia
|
J:58502
|
tail telangiectasia
|
J:58502
|
Engtm1Mle/Eng+
(129P2/OlaHsd-Engtm1Mle)
|
ear telangiectasia
|
J:58502
|
tail telangiectasia
|
J:58502
|
Engtm2.1Hma/Engtm2.1Hma Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
abnormal vascular wound healing
|
J:227170,
J:212952
|
Engtm2.1Hma/Engtm2.1Hma Tg(Tal1-cre/ERT)1Jrg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal vascular wound healing
|
J:227170
|
Entpd1tm1Rdr/Entpd1tm1Rdr
(involves: 129S2/SvPas)
|
abnormal vascular endothelial cell physiology
|
J:57505
|
Eogttm1.1Okaj/Eogttm1.1Okaj Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * C57BL/6J * SJL)
|
increased vascular permeability
|
J:254752
|
Eogttm1.2Okaj/Eogttm1.2Okaj
(involves: C57BL/6J * DBA/2)
|
increased vascular permeability
|
J:254752
|
Eogttm1.2Okaj/Eogttm1.2Okaj Notch1tm1Con/Notch1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA/2)
|
increased vascular permeability
|
J:254752
|
Eogttm1.2Okaj/Eogttm1.2Okaj Rbpjtm1.1Hon/Rbpj+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * DBA/2)
|
increased vascular permeability
|
J:254752
|
Epas1tm1.1Mcs/Epas1+
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
abnormal type I cell of carotid body physiology
|
J:302384
|
Epas1tm1Mcs/Epas1tm1.1Mcs Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
abnormal type I cell of carotid body physiology
|
J:302384
|
Epn1tm1.1Wami/Epn1tm1.1Wami Epn2tm1Ocr/Epn2tm1Ocr Tg(Cdh5-cre/ERT2)CIVE23Mlia/0
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal vascular endothelial cell physiology
|
J:193966
|
increased vascular endothelial cell proliferation
|
J:193966
|
increased vascular permeability
|
J:193966
|
Ergtm1.1Path/Ergtm1.1Path
(Not Specified)
|
increased vascular endothelial cell proliferation
|
J:227456
|
Errfi1tm1Gvw/Errfi1tm1Gvw
(Not Specified)
|
pathological neovascularization
|
J:100927
|
Esamtm1Dvst/Esamtm1Dvst
(B6.129-Esam1tm1Dvst)
|
decreased vascular permeability
|
J:124397
|
Esm1tm1.1Rha/Esm1tm1.1Rha
(involves: 129S6/SvEvTac * BALB/c * C57BL/6 * C57BL/6NTac)
|
abnormal vascular endothelial cell physiology
|
J:246778
|
decreased vascular permeability
|
J:246778
|
Esr1tm1.1Ics/Esr1tm1.1Ics
(involves: C57BL/6NTac)
|
abnormal vascular endothelial cell physiology
|
J:206373
|
abnormal vasodilation
|
J:206373
|
Esr1tm1.1Mma/Esr1tm1.1Mma
(involves: 129S2/SvPas)
|
abnormal vasodilation
|
J:206373
|
Esr1tm1.1Pws/Esr1tm1.1Pws
(involves: C57BL/6 * CBA)
|
abnormal vascular wound healing
|
J:163783
|
Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal vascular smooth muscle physiology
|
J:73898
|
increased vasoconstriction
|
J:73898
|
Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd)
|
increased vasodilation
|
J:64165
|
Ets1tm1Jml/Ets1tm1Jml Ets2tm2Rgo/Ets2tm2Rgo
(involves: 129S/SvEv * C57BL/6 * FVB/N)
|
increased vascular endothelial cell apoptosis
|
J:151187
|
Ets1tm1Jml/Ets1tm1Jml Ets2tm5.1Rgo/Ets2tm5.1Rgo Tg(Tek-cre)1Ywa/0
(involves: 129S/SvEv * C57BL/6 * FVB/N)
|
increased vascular endothelial cell apoptosis
|
J:151187
|
F2rtm1Pago/F2rtm1Pago
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal vascular wound healing
|
J:103347
|
decreased vascular permeability
|
J:124465
|
F2rtm1Pago/F2rtm1Pago F3tm1.1Dwr/F3tm1.1Dwr
(B6.129-F3tm1.1Dwr F2rtm1Pago)
|
abnormal induced retina neovascularization
|
J:135087
|
F3tm1.1Dwr/F3tm1.1Dwr
(involves: 129S1/Sv * 129X1/SvJ * MF1 * Swiss)
|
abnormal vascular smooth muscle physiology
|
J:111390
|
abnormal vascular wound healing
|
J:111390
|
increased vascular smooth muscle cell proliferation
|
J:111390
|
F3tm1.1Dwr/F3tm1.1Dwr
(B6.129-F3tm1.1Dwr)
|
abnormal induced retina neovascularization
|
J:135087
|
F3tm1Jld/F3tm1Jld
(involves: 129P2/OlaHsd * NIH Black Swiss)
|
abnormal blood vessel physiology
|
J:33831
|
Fancfem1(IMPC)J/Fancfem1(IMPC)J
(C57BL/6NJ-Fancfem1(IMPC)J/Mmjax)
|
cornea vascularization
|
J:211773
|
Faslpr/Faslpr
(MRL/Mp-Faslpr)
|
blood vessel inflammation
|
J:28885
|
Faslpr/Faslpr
(MRL/MpJ-Faslpr)
|
blood vessel inflammation
|
J:137066
|
Faslpr/Faslpr Fcer1gtm1Tks/Fcer1gtm1Tks
(MRL.Cg-Fcer1gtm1Tks Faslpr)
|
arteritis
|
J:106188
|
Fbln5tm1Eno/Fbln5tm1Eno
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal blood vessel physiology
|
J:96831
|
abnormal vascular smooth muscle physiology
|
J:96831
|
abnormal vascular wound healing
|
J:96831
|
Fbn1tm2Rmz/Fbn1tm2Rmz
(involves: 129S1/Sv * 129X1/SvJ)
|
aortitis
|
J:54081
|
Fbn1Tsk Bloc1s6+/Fbn1+ Bloc1s6pa
(B6.Cg-Fbn1Tsk +/+ Bloc1s6pa/J)
|
abnormal vascular endothelial cell physiology
|
J:81020
|
abnormal vasodilation
|
J:81020
|
Fbn2em1(IMPC)Rbrc/Fbn2em1(IMPC)Rbrc
(C57BL/6NJcl-Fbn2em1(IMPC)Rbrc/Rbrc)
|
cornea vascularization
|
J:211773
|
Fcer1atm1Knt/Fcer1atm1Knt Tg(SV40/HTLV-FCER1A)1Bhk/0
(either: (involves: 129 * C57BL/6) or (involves: 129 * C57BL/6 * DBA/2))
|
increased vascular permeability
|
J:113572
|
Fgf2tm1Doe/Fgf2tm1Doe
(involves: 129P2/OlaHsd * Black Swiss)
|
decreased vasoconstriction
|
J:45775
|
Fgfr2tm1Ewj/Fgfr2+ Tg(EIIa-cre)C5379Lmgd/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
abnormal vasodilation
|
J:101174
|
Fignfi/Fignfi
(mixed)
|
cornea vascularization
|
J:13035
|
Fkbpltm1(KOMP)Wtsi/Fkbpl+
(involves: C57BL/6N)
|
abnormal blood vessel physiology
|
J:226964
|
Fli1tm1Matr/Fli1tm1Matr Tg(Tek-cre)12Flv/0
(B6.Cg-Fli1tm1Matr Tg(Tek-cre)12Flv)
|
increased vascular permeability
|
J:158658
|
Flnatm1.1Caw/Y H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
abnormal vascular endothelial cell physiology
|
J:118252
|
Flt1tm1.1Fong/Flt1tm1.1Fong Gt(ROSA)26Sortm1(cre/ERT2)Thl/Gt(ROSA)26Sor+
(involves: 129S6/SvEvTac * C57BL/6NCr * CD-1)
|
increased vascular permeability
|
J:202202
|
Flt1tm1Gne/Flt1tm1Gne
(Not Specified)
|
cornea vascularization
|
J:114973
|
Flt1tm1Msh/Flt1tm1Msh
(involves: 129S4/SvJae * C57BL/6J)
|
cornea vascularization
|
J:114973
|
Foxc1ch/Foxc1+
(CHMU/Le)
|
cornea vascularization
|
J:61775
|
Foxc1tm1Blh/Foxc1+ Foxc2tm1Blh/Foxc2+
(involves: 129S6/SvEvTac * Black Swiss)
|
cornea vascularization
|
J:61775
|
Foxe3dyl/Foxe3dyl
(BALB/cLiA-Foxe3dyl)
|
cornea vascularization
|
J:6131
|
Foxe3tm1Mjam/Foxe3tm1Mjam
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:232427
|
Foxe3tm1Pca/Foxe3tm1Pca
(C.129-Foxe3tm1Pca)
|
cornea vascularization
|
J:119940
|
Foxn1nu/Foxn1+
(involves: BALB/c)
|
cornea vascularization
|
J:12543
|
Frem2em1Hali/Frem2em2Hali
(C57BL/6J-Frem2em1Hali Frem2em2Hali)
|
cornea vascularization
|
J:279933
|
Galctwi/Galctwi Il6+/?
(involves: 129S2/SvPas * C57BL/6J * CE/J)
|
abnormal blood-brain barrier function
|
J:56656
|
Galctwi/Galctwi Il6tm1Kopf/Il6tm1Kopf
(involves: 129S2/SvPas * C57BL/6J * CE/J)
|
abnormal blood-brain barrier function
|
J:56656
|
Gas6tm1Pec/Gas6tm1Pec
(involves: 129S1/Sv * 129X1/SvJ)
|
increased vascular permeability
|
J:198769
|
Gata5tm1.2Nemr/Gata5tm1.2Nemr
(Not Specified)
|
abnormal vasodilation
|
J:227997
|
Gfaptm1Ldtk/Gfaptm1Ldtk
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal blood-brain barrier function
|
J:77630
|
Gfaptm1Pkny/Gfaptm1Pkny Vimtm1Cba/Vimtm1Cba
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
increased vasodilation
|
J:124385
|
Git1tm1Bcb/Git1tm1Bcb
(involves: 129 * C57BL/6)
|
decreased vascular endothelial cell proliferation
|
J:158935
|
Gja1tm1Kdr/Gja1tm1Kdr
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vascular smooth muscle physiology
|
J:212895
|
Gja1tm3.1Clo/Gja1tm3.1Clo
(B6.Cg-Gja1tm1.1Clo)
|
abnormal vascular smooth muscle cell proliferation
|
J:212895
|
abnormal vascular wound healing
|
J:212895
|
Gja4tm1Paul/Gja4tm1Paul Gja5tm1Paul/Gja5tm1Paul
(involves: 129S4/SvJae * C57BL/6)
|
increased vasodilation
|
J:80178
|
Gjb6tm1Kwi/Gjb6tm1Kwi
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal blood-inner ear barrier function
|
J:120823
|
Glultm1.1Ncd/Glultm1.1Ncd Emx1tm1(cre)Krj/Emx1+
(B6.Cg-Glultm1.1Ncd Emx1tm1(cre)Krj)
|
abnormal blood vessel physiology
|
J:272643
|
Gna11tm1Soff/Gna11tm1Soff Gnaqtm2Soff/Gnaqtm2Soff X/Tg(Myh11-icre/ERT2)1Soff
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB/N)
|
decreased vasoconstriction
|
J:141641
|
Gna11tm1Soff/Gna11tm1Soff Gnaqtm2Soff/Gnaqtm2Soff Tg(Tek-icre/ERT2)1Soff/?
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB/N)
|
decreased vascular permeability
|
J:146132
|
Gna11tm1Soff/Gna11tm1Soff Gnaqtm2Soff/Gnaqtm2Soff Tg(Tek-icre/ERT2)1Soff/0
(B6N.Cg-Gna11tm1Soff Gnaqtm2Soff Tg(Tek-icre/ERT2)1Soff)
|
abnormal vascular wound healing
|
J:224523
|
decreased vasodilation
|
J:224523
|
Gna12tm1Citb/Gna12tm1Citb Gna13tm2.1Soff/Gna13tm2.1Soff X/Tg(Myh11-icre/ERT2)1Soff
(involves: 129S1/Sv * FVB/N)
|
decreased vasoconstriction
|
J:141641
|
Gpr17tm1Dgen/Gpr17tm1Dgen
(B6.129-Gpr17tm1Dgen)
|
increased vascular permeability
|
J:150814
|
Gpsm1tm1.1Lajb/Gpsm1tm1.1Lajb
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N * SJL)
|
increased vasodilation
|
J:138126
|
Gpx3tm1Jlos/Gpx3tm1Jlos
(B6N.Cg-Gpx3tm1Jlos)
|
abnormal blood vessel physiology
|
J:183744
|
Gsntm1Djk/Gsntm1Djk
(involves: 129S4/SvJae * C57BL/6)
|
increased vascular permeability
|
J:94614
|
Gt(ROSA)26Sortm1(CAG-Rhoj,-EGFP)Auem/Gt(ROSA)26Sortm1(CAG-Rhoj,-EGFP)Auem Tg(CAG-cre/Esr1*)1Egwa/0
(involves: C57BL/6 * CBA * DBA/2)
|
abnormal induced retina neovascularization
|
J:173943
|
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+ Tg(CAG-ANGPT1*)5Yo/0
(involves: 129S4/SvJae * C57BL/6NCrlj * CBA/JNCrlj)
|
decreased vascular permeability
|
J:213456
|
Gt(ROSA)26Sortm1(DTA)Mrc/? Tg(Rlbp1-cre/ERT2,-EGFP)1Wshn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA)
|
retina neovascularization
|
J:192243
|
Gt(ROSA)26Sortm1(MAML1)Wsp/Gt(ROSA)26Sor+ Tg(KRT14-rtTA)F42Efu/0 Tg(tetO-cre)1Jaw/0
(involves: 129 * C57BL/6 * FVB)
|
cornea vascularization
|
J:194073
|
Gt(ROSA)26Sortm1(PDGFB)Cbet/Gt(ROSA)26Sor+ Pdgfbtm1Cbet/Pdgfbtm1Cbet Tg(Tek-cre)1Ywa/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * SJL)
|
impaired blood-brain barrier function
|
J:166532
|
Gt(ROSA)26Sortm1(PDGFB)Cbet/Gt(ROSA)26Sortm1(PDGFB)Cbet Pdgfbtm1Cbet/Pdgfbtm1Cbet Tg(Tek-cre)1Ywa/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * SJL)
|
impaired blood-brain barrier function
|
J:166532
|
Gt(ROSA)26Sortm1(Rybp/EGFP)Cve/Gt(ROSA)26Sor+ Tmem163Tg(ACTB-cre)2Mrt/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
cornea vascularization
|
J:134428
|
Gt(ROSA)26Sortm1(Rybp/EGFP)Cve/Gt(ROSA)26Sortm1(Rybp/EGFP)Cve Tmem163Tg(ACTB-cre)2Mrt/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
cornea vascularization
|
J:134428
|
Gt(ROSA)26Sortm1(Tgfbr1*)Crm/Gt(ROSA)26Sor+ Tg(Col1a2-cre/ERT,-ALPP)7Cpd/0
(involves: 129S7/SvEvBrd * C57BL/6 * DBA/2)
|
abnormal blood vessel physiology
|
J:134135
|
Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/Gt(ROSA)26Sor+ Polr1atm1a(EUCOMM)Hmgu/Polr1atm1c(EUCOMM)Hmgu Tg(Wnt1-cre/Esr1*)10Rth/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)
|
increased vascular permeability
|
J:335489
|
Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/Gt(ROSA)26Sor+ Polr1atm1c(EUCOMM)Hmgu/Polr1atm1c(EUCOMM)Hmgu Tg(Wnt1-cre/Esr1*)10Rth/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)
|
increased vascular permeability
|
J:335489
|
Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/Gt(ROSA)26Sor+ Polr1atm1d(EUCOMM)Hmgu/Polr1atm1c(EUCOMM)Hmgu Tg(Wnt1-cre/Esr1*)10Rth/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)
|
increased vascular permeability
|
J:335489
|
Gt(ROSA)26Sortm4(HIF2A*)Kael/Gt(ROSA)26Sor+ Tg(KRT14-cre)1Ipc/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6 * SJL)
|
increased vascular permeability
|
J:144666
|
Gt(ROSA)26Sortm7.1(CAG-EGFP/RNAi:Tyr)Maoh/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * C57BL/6)
|
choroidal neovascularization
|
J:173808
|
Gucy1a1tm1.1Dko/Gucy1a1tm1.1Dko
(involves: C57BL/6)
|
abnormal vasodilation
|
J:110362
|
Gucy1b1tm1.1Frb/Gucy1b1tm1.1Frb
(involves: 129 * C57BL/6 * FVB/N)
|
abnormal vasodilation
|
J:121321
|
Gucy1b1tm1.2Frb/Gucy1b1tm1.2Frb X/Tg(Myh11-icre/ERT2)1Soff
(B6.Cg-Gucy1b1tm1.2Frb Tg(Myh11-icre/ERT2)1Soff)
|
decreased vasodilation
|
J:186053
|
Gulotm1Mae/Gulotm1Mae
(involves: 129 * C57BL/6)
|
increased vascular permeability
|
J:59931
|
H2axtm1Nus/H2axtm1Nus
(Not Specified)
|
decreased vascular endothelial cell proliferation
|
J:194603
|
increased vascular endothelial cell apoptosis
|
J:149487
|
retina neovascularization
|
J:149487
|
H2axtm1Nus/H2axtm2.1Fwa Tg(Cdh5-cre)7Mlia/0
(involves: 129S6/SvEvTac * FVB/N)
|
retina neovascularization
|
J:149487
|
Hhipl1tm1a(KOMP)Wtsi/Hhipl1tm1a(KOMP)Wtsi
(B6J.B6N-Hhipl1tm1a(KOMP)Wtsi)
|
abnormal vascular smooth muscle physiology
|
J:280707
|
decreased vascular smooth muscle cell proliferation
|
J:280707
|
Hif1atm3Rsjo/Hif1atm3Rsjo Hprt1tm1(Pck1-cre)Vhh/Y Vhltm1Jae/Vhltm1Jae
(involves: 129 * BALB/c * C57BL/6)
|
abnormal vasodilation
|
J:97652
|
Hif1atm3Rsjo/Hif1atm3Rsjo Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
decreased vascular endothelial cell proliferation
|
J:94773
|
Hif1atm3Rsjo/Hif1atm3Rsjo Vhltm1Jae/Vhltm1Jae Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * BALB/c * C57BL/6 * DBA)
|
abnormal vasodilation
|
J:97652
|
Higd1cem2Chaa/Higd1cem2Chaa
(C57BL/6J-Higd1cem2Chaa)
|
abnormal carotid body physiology
|
J:345095
|
abnormal type I cell of carotid body physiology
|
J:345095
|
Hmgxb4tm1.2Zhji/Hmgxb4tm1.2Zhji
(B6(Cg)-Hmgxb4tm1.2Zhji)
|
decreased vascular permeability
|
J:302603
|
Hmox1tm1Mlee/Hmox1tm1Mlee
(B6.129S2-Hmox1tm1Mlee)
|
abnormal vascular smooth muscle physiology
|
J:106600
|
increased vascular smooth muscle cell proliferation
|
J:106600
|
Hprt1tm1(Pck1-cre)Vhh/Y Vhltm1Jae/Vhltm1Jae
(involves: 129P2/OlaHsd * 129S4/SvJae * BALB/c * C57BL/6)
|
abnormal vasodilation
|
J:97652
|
Hprt1tm1(Rcan1)Zyga/Hprt1+
(B6.129P2-Hprt1tm1(Rcan1)Zyga)
|
decreased vascular endothelial cell proliferation
|
J:150286
|
Hprt1tm4(Tek-IGF1R)Geno/Y
(B6.129P2-Hprt1tm4(Tek-IGF1R)Geno)
|
abnormal vascular endothelial cell physiology
|
J:208523
|
abnormal vascular wound healing
|
J:208523
|
increased vasoconstriction
|
J:208523
|
Hpsetm1Jpli/Hpsetm1Jpli
(B6.129-Hpsetm1Jpli)
|
pathological neovascularization
|
J:148281
|
Hrh3tm1Twl/Hrh3tm1Twl
(B6.129X1-Hrh3tm1Twl)
|
impaired blood-brain barrier function
|
J:122269
|
Icam1tm1Bay/Icam1tm1Bay
(B6.129S7-Icam1tm1Bay/J)
|
decreased susceptibility to induced choroidal neovascularization
|
J:119416
|
Id1tm1Zhu/Id1tm1Zhu
(involves: 129S1/Sv * C57BL/6J)
|
increased vascular endothelial cell apoptosis
|
J:125521
|
increased vascular permeability
|
J:125521
|
Ido1tm1.1Mkks/Ido1tm1.1Mkks
(B6.Cg-Ido1tm1.1Mkks)
|
abnormal vasodilation
|
J:229059
|
Ier3tm1Mxw/Ier3tm1Mxw
(involves: 129 * C57BL/6)
|
decreased vasodilation
|
J:157504
|
Ifi27tm1Npm/Ifi27tm1Npm
(involves: 129S1/Sv * 129X1/SvJ * Swiss Webster)
|
abnormal vascular wound healing
|
J:212520
|
Ifnar1tm1Agt/Ifnar1tm1Agt
(involves: 129S2/SvPas)
|
cornea vascularization
|
J:114973
|
Ifngtm1Ts/Ifngtm1Ts
(involves: 129S7/SvEvBrd)
|
cornea vascularization
|
J:114973
|
Ifngr1tm1Agt/Ifngr1tm1Agt
(involves: 129S7/SvEvBrd)
|
abnormal vascular endothelial cell physiology
|
J:114203
|
aortitis
|
J:115139
|
arteritis
|
J:115139
|
Igf1rtm2Arge/Igf1r+ Tg(Tek-cre)1Ywa/0
(B6.Cg-Tg(Tek-cre)1Ywa Igf1rtm2Arge)
|
abnormal vascular endothelial cell physiology
|
J:208523
|
abnormal vascular wound healing
|
J:208523
|
Il1btm1Lvp/Il1btm1Lvp
(involves: 129S7/SvEvBrd * C57BL/6 * C57BL/10 * RIIIS)
|
abnormal blood-brain barrier function
|
J:105009
|
Il1btm1Yiw/Il1btm1Yiw
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vascular wound healing
|
J:107324
|
Il1r1tm1Imx/Il1r1tm1Imx
(B6.129S7-Il1r1tm1Imx/J)
|
abnormal vascular wound healing
|
J:107324
|
Il1rntm1Nick/Il1rn+
(involves: 129P2/OlaHsd * MF1)
|
aortitis
|
J:59410
|
Il1rntm1Nick/Il1rntm1Nick
(involves: 129P2/OlaHsd * MF1)
|
aortitis
|
J:59410
|
Il1rntm1Nick/Il1rntm1Nick
(involves: 129P2/OlaHsd * MF1 * BALB/cAnNHsd)
|
aortitis
|
J:89034
|
Il1rntm1Nick/Il1rntm1Nick
(involves: BALB/cAnNHsd)
|
aortitis
|
J:89034
|
pathological neovascularization
|
J:89034
|
Il1rntm1Nick/Il1rntm1Nick
(involves: BALB/cAnNHsd * C57BL/6)
|
aortitis
|
J:89034
|
Il1rntm1Yiw/Il1rntm1Yiw
(B6.129-Il1rntm1Yiw)
|
abnormal vascular wound healing
|
J:103068
|
Il10tm1Cgn/Il10tm1Cgn
(B6.129P2-Il10tm1Cgn/J)
|
decreased susceptibility to induced choroidal neovascularization
|
J:134144
|
decreased vasoconstriction
|
J:59742
|
increased vasoconstriction
|
J:146372
|
Il10tm1Cgn/Il10tm1Cgn
(129S.Cg-Il10tm1Cgn)
|
decreased vasoconstriction
|
J:59742
|
Inf2tm1.1(KOMP)Vlcg/Inf2tm1.1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal blood vessel physiology
|
J:255715
|
Ing5em1(IMPC)J/Ing5em1(IMPC)J
(C57BL/6NJ-Ing5em1(IMPC)J/Mmjax)
|
cornea vascularization
|
J:211773
|
Inhbbtm1b(EUCOMM)Hmgu/Inhbbtm1b(EUCOMM)Hmgu
(C57BL/6N-Inhbbtm1b(EUCOMM)Hmgu/Bay)
|
cornea vascularization
|
J:211773
|
Ins2Akita/Ins2+
(C57BL/6-Ins2Akita/J)
|
increased vascular permeability
|
J:99412
|
Irag1tm2.1Jens/Irag1tm2.1Jens
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vascular smooth muscle physiology
|
J:175887
|
Irf1tm1Mak/Irf1tm1Mak
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal vascular wound healing
|
J:118512
|
Irs1tm1Tka/Irs1tm1Tka
(involves: C57BL/6 * CBA)
|
abnormal vascular wound healing
|
J:99746
|
decreased vasodilation
|
J:99746
|
Irs2tm1Tka/Irs2tm1Tka
(involves: C57BL/6 * CBA)
|
abnormal vascular wound healing
|
J:99746
|
decreased vasodilation
|
J:99746
|
Itgb2tm1Bay/Itgb2tm1Bay
(B6.129S7-Itgb2tm1Bay/J)
|
decreased susceptibility to induced choroidal neovascularization
|
J:119416
|
Itgb3tm1Hyn/Itgb3tm1Hyn
(involves: 129S2/SvPas * C57BL/6)
|
abnormal induced retina neovascularization
|
J:73752
|
Kat14tm1a(KOMP)Wtsi/Kat14tm1a(KOMP)Wtsi
(B6JTyr;B6N-Kat14tm1a(KOMP)Wtsi/Wtsi)
|
cornea vascularization
|
J:165965
|
Kat14tm1a(KOMP)Wtsi/Kat14tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
cornea vascularization
|
J:213427
|
Kcna5tm1(Kcna1)Lndn/Kcna5tm1(Kcna1)Lndn
(involves: C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:70694
|
decreased vasoconstriction
|
J:70694
|
Kcnj2tm1Swz/Kcnj2tm1Swz
(involves: 129S1/Sv * 129X1/SvJ * FVB)
|
abnormal vasodilation
|
J:78077
|
Kcnj8em1Nich/Kcnj8+
(involves: C57BL/6J * CBA/J)
|
abnormal vascular smooth muscle physiology
|
J:281903
|
increased vasodilation
|
J:281903
|
Kcnj8tm1Sse/Kcnj8tm1Sse
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
coronary artery spasm
|
J:76195
|
Kcnj8tm1Sse/Kcnj8tm1Sse
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vascular smooth muscle physiology
|
J:202037
|
Kcnk6tm1Tigm/Kcnk6tm1Tigm
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:194443
|
abnormal vasoconstriction
|
J:194443
|
Kcnmb1tm1Ltor/Kcnmb1tm1Ltor
(Not Specified)
|
increased vasoconstriction
|
J:195657
|
Kcnmb1tm1Pong/Kcnmb1tm1Pong
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vascular smooth muscle physiology
|
J:82471
|
increased vasoconstriction
|
J:82471
|
Kcnmb1tm1Rwa/Kcnmb1tm1Rwa
(involves: 129X1/SvJ * C57BL/6)
|
abnormal vasoconstriction
|
J:65415
|
Kcnn4tm1Rklr/Kcnn4tm1Rklr
(involves: 129S/SvEv * C57BL/6)
|
decreased vasodilation
|
J:124858
|
Kctd1em1(IMPC)J/Kctd1em1(IMPC)J
(C57BL/6NJ-Kctd1em1(IMPC)J/Mmjax)
|
cornea vascularization
|
J:211773
|
Kdrtm1Jrt/Kdrtm1.1Jamb Tg(CAG-cre/Esr1*)1Egwa/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal induced retina neovascularization
|
J:173943
|
KitW-sh/KitW-sh
(involves: C57BL/6J)
|
abnormal vascular permeability
|
J:197334
|
KitW/KitW-v
((WB/ReJ x C57BL/6J-KitW-v/J)F1-KitW/KitW-v/J)
|
decreased vascular permeability
|
J:84660
|
Klkl/Kl+
(involves: C3H/HeJ * C57BL/6J)
|
abnormal blood vessel physiology
|
J:76383
|
Klf5tm1Rng/Klf5+
(involves: 129/Sv * C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:78275
|
abnormal vascular wound healing
|
J:78275
|
Klf15tm1Jain/Klf15tm1Jain
(involves: 129X1/SvJ)
|
blood vessel inflammation
|
J:203920
|
Klhl20Gt(XF202)Byg/Klhl20Gt(XF202)Byg
(B6.129P2-Klhl20Gt(XF202)Byg)
|
cornea vascularization
|
J:196827
|
retina neovascularization
|
J:196827
|
Klk1tm1Pmtn/Klk1tm1Pmtn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased vasodilation
|
J:67868
|
Klk1tm1Pmtn/Klk1tm1Pmtn
(involves: 129/Sv * C57BL/6)
|
decreased vasodilation
|
J:103928
|
Krit1tm1Kwhi/Krit1tm1.1Kwhi Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl * CBA)
|
abnormal blood vessel physiology
|
J:215458
|
abnormal vascular endothelial cell physiology
|
J:215458
|
telangiectasia
|
J:215458
|
Krt1tm1Tmm/Krt1tm1Tmm
(involves: 129 * C57BL/6)
|
increased vascular permeability
|
J:200244
|
Lattm1.1Mal/Lattm1.1Mal
(involves: 129S2/SvPas)
|
phlebitis
|
J:262891
|
Ldlrtm1Her/Ldlrtm1Her Lrp1tm2Her/Lrp1tm2Her Tg(Tagln-cre)1Her/0
(involves: 129S7/SvEvBrd * C57BL/6J * SJL)
|
increased vascular smooth muscle cell proliferation
|
J:82871
|
Lepob/Lepob
(involves: STOCK Mlphln a Tgfawa1 Cdh23v Ednrbs)
|
abnormal vascular wound healing
|
J:135034
|
Leprdb/Leprdb
(involves: C57BLKS/J)
|
abnormal vascular wound healing
|
J:135034
|
increased vasoconstriction
|
J:106597
|
Leprtm1Mgmj/Leprtm1Mgmj
(B6.129-Leprtm1Mgmj)
|
abnormal vascular wound healing
|
J:135034
|
Lgr4Gt(LST020)Byg/Lgr4Gt(LST020)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
cornea vascularization
|
J:134299
|
Liftm1Stw/Liftm1Stw
(involves: 129S1/Sv * C57BL/6)
|
abnormal induced retina neovascularization
|
J:137720
|
increased vascular endothelial cell proliferation
|
J:137720
|
Limk2Gt(OST80053)Lex/Limk2Gt(OST80053)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
retina neovascularization
|
J:192231
|
Limk2whe/Limk2whe
(B6.Cg-Lepob Limk2whe/GrsrJ)
|
cornea vascularization
|
J:127016
|
Lipgtm1Tq/Lipgtm1Tq
(involves: 129S6/SvEvTac)
|
abnormal vascular endothelial cell physiology
|
J:95158
|
Lmnatm1.1Bliu/Lmna+
(involves: C57BL/6 * FVB/N)
|
abnormal vasodilation
|
J:287256
|
Lmnatm1.1Bliu/Lmnatm1.1Bliu
(involves: C57BL/6 * FVB/N)
|
abnormal vasodilation
|
J:287256
|
Lmnatm1.1Otin/Lmna+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:211388
|
Lmnatm1Bliu/Lmnatm1Bliu Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * SJL)
|
abnormal vasodilation
|
J:287256
|
Lmx1bIcst/Lmx1b+
(involves: BALB/cAnN * C3H/HeN)
|
cornea vascularization
|
J:215517
|
Lmx1btm1Rjo/Lmx1btm1Rjo
(involves: 129S7/SvEvBrd)
|
cornea vascularization
|
J:161793
|
Lmx1btm1Rjo/Lmx1btm4.1Rjo H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S7/SvEvBrd * C57BL/6J * CBA/J)
|
cornea vascularization
|
J:161793
|
Lmx1btm1Rjo/Lmx1btm4.1Rjo Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA)
|
cornea vascularization
|
J:161793
|
Lpoem1Zlu/Lpoem1Zlu
(involves: C57BL/6 * SJL)
|
aortitis
|
J:307289
|
arteritis
|
J:307289
|
blood vessel inflammation
|
J:307289
|
Lrp1tm2Her/Lrp1tm2Her Tg(Tagln-cre)1Her/0
(B6.Cg-Lrp1tm2Her Tg(Tagln-cre)1Her)
|
abnormal vascular smooth muscle physiology
|
J:167799
|
abnormal vascular wound healing
|
J:167799
|
decreased vasoconstriction
|
J:167799
|
Lrp5Gt(OST164883)Lex/Lrp5Gt(OST164883)Lex
(involves: 129S5/SvEvBrd)
|
increased vascular permeability
|
J:154863
|
Ltc4stm1Blam/Ltc4stm1Blam
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased vascular permeability
|
J:87909
|
Lypla1tm1Sem/Lypla1tm1Sem Tg(Tek-cre)12Flv/0
(B6(Cg)-Lypla1tm1Sem Tg(Tek-cre)12Flv)
|
abnormal vascular endothelial cell adhesion
|
J:302677
|
abnormal vascular endothelial cell physiology
|
J:302677
|
Lyz2tm1(cre)Ifo/Lyz2+ St18tm1c(KOMP)Wtsi/St18tm1c(KOMP)Wtsi
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)
|
increased vascular permeability
|
J:298828
|
Map3k1tm1Glj/Map3k1tm1Glj
(involves: 129S/SvEv)
|
abnormal vascular smooth muscle physiology
|
J:108989
|
abnormal vascular wound healing
|
J:108989
|
Map3k1tm1Yxia/Map3k1tm1Yxia
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
retina neovascularization
|
J:176244
|
Mapk7tm1Jdl/Mapk7tm1Jdl Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal vascular permeability
|
J:89215
|
Mapre3tm1c(EUCOMM)Wtsi/Mapre3tm1c(EUCOMM)Wtsi Tg(Tek-icre/ERT2)1Soff/0
(involves: C57BL/6N * FVB/N)
|
abnormal vascular permeability
|
J:224855
|
Mcph1tm1a(EUCOMM)Wtsi/Mcph1tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Mcph1tm1a(EUCOMM)Wtsi/Wtsi)
|
cornea vascularization
|
J:175295
|
Mcph1tm1a(EUCOMM)Wtsi/Mcph1tm1a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
cornea vascularization
|
J:213427
|
Med1tm1Jkr/Med1tm1Jkr
(involves: 129P2/OlaHsd * C57BL/6)
|
increased vascular permeability
|
J:74328
|
Mfsd2atm1Lex/Mfsd2atm1Lex
(B6;129S5-Mfsd2atm1Lex/Mmucd)
|
abnormal vascular endothelial cell physiology
|
J:210589
|
impaired blood-brain barrier function
|
J:210589
|
Mir21atm1.1Zqy/Mir21atm1.1Zqy Tg(Tek-cre)12Flv/0
(involves: 129S/SvEv * C3H * C57BL/6 * SJL)
|
abnormal blood vessel physiology
|
J:199907
|
decreased vasodilation
|
J:199907
|
Mir143tm1.1Eno/Mir143tm1.1Eno
(involves: 129S/SvEv * C57BL/6)
|
abnormal vascular wound healing
|
J:152458
|
Mir145atm1Eno/Mir145atm1Eno
(involves: 129S/SvEv * C57BL/6)
|
abnormal vascular wound healing
|
J:152458
|
Mir195atm1Narl/Mir195atm1Narl Tg(Ctsk-RFP,-cre)7Narl/0
(involves: C57BL/6)
|
impaired blood-brain barrier function
|
J:297580
|
Mirc32tm1.2Eno/Mirc32tm1.2Eno
(involves: 129S/SvEv * C57BL/6)
|
abnormal vascular wound healing
|
J:152458
|
Mirc32tm1Gcon/Mirc32tm1Gcon
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vascular smooth muscle physiology
|
J:159593
|
Mirc32tm1Thbr/Mirc32tm1Thbr
(involves: 129/Sv * C57BL/6)
|
abnormal vascular wound healing
|
J:152702
|
decreased vasoconstriction
|
J:152702
|
Mirc55tm1.1Eno/Mirc55tm1.1Eno
(Not Specified)
|
decreased vascular endothelial cell proliferation
|
J:139708
|
Mmp2tm1Ito/Mmp2tm1Ito
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal vascular smooth muscle physiology
|
J:101783
|
Mmp2tm1Ito/Mmp2tm1Ito
(involves: 129P2/OlaHsd)
|
abnormal induced retina neovascularization
|
J:113620
|
Mmp2tm1Ito/Mmp2tm1Ito Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
decreased susceptibility to induced choroidal neovascularization
|
J:86805
|
Mmp2tm1Ito/Mmp2tm1Ito Timp3tm1Osya/Timp3tm1Osya
(involves: 129P2/OlaHsd * C57BL/6)
|
aortitis
|
J:193744
|
Mmp7tm1Lmm/Mmp7tm1Lmm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal induced retina neovascularization
|
J:119224
|
Mmp9tm1Arnd/Mmp9tm1Arnd
(B6.129P2-Mmp9tm1Arnd)
|
increased vascular permeability
|
J:110450
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129S6/SvEvTac)
|
abnormal induced retina neovascularization
|
J:113620
|
abnormal vascular smooth muscle physiology
|
J:109006
|
abnormal vascular wound healing
|
J:109006
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal vascular smooth muscle physiology
|
J:101783
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(FVB.Cg-Mmp9tm1Tvu/J)
|
enhanced blood-brain barrier function
|
J:153406
|
Mmp11tm1Mrio/Mmp11tm1Mrio
(either: (involves: 129S2/SvPas) or (involves: 129S2/SvPas * C57BL/6))
|
abnormal vascular wound healing
|
J:59827
|
Mmrn2tm1Monm/Mmrn2tm1Monm
(involves: C57BL/6NCrl)
|
increased vascular permeability
|
J:298039
|
Mrgprdtm5Mjz/Mrgprdtm5Mjz
(B6.129S1-Mrgprdtm5Mjz/Mmnc)
|
increased vasodilation
|
J:269603
|
MtapGt(RRK081)Byg/Mtap+
(129P2/OlaHsd-MtapGt(RRK081)Byg)
|
arteritis
|
J:123675
|
Myh9tm1.1(MYH9*)Mjk/Myh9+
(B6.Cg-Myh9tm1.1(MYH9*)Mjk)
|
cornea vascularization
|
J:175367
|
Myh11tm1.1Dmmz/Myh11tm1.1Dmmz
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:212664
|
abnormal vascular wound healing
|
J:212664
|
decreased vasoconstriction
|
J:212664
|
increased vascular smooth muscle cell proliferation
|
J:212664
|
Myl9tm1Mzhu/Myl9tm1Mzhu Tg(Acta2-cre)#Xya/0
(involves: C57BL/6 * CBA)
|
abnormal vascular smooth muscle physiology
|
J:308237
|
Myoftm1Mcn/Myoftm1Mcn
(Not Specified)
|
decreased vascular permeability
|
J:163126
|
Nadsyn1tm1b(KOMP)Wtsi/Nadsyn1tm1b(KOMP)Wtsi
(C57BL/6N-Nadsyn1tm1b(KOMP)Wtsi/Ucd)
|
cornea vascularization
|
J:211773
|
Naxetm1.1Lfan/Naxetm1.1Lfan
(involves: C57BL/6)
|
pathological neovascularization
|
J:261549
|
Ncf1tm1Hbd/Ncf1tm1Hbd
(involves: 129)
|
abnormal vascular endothelial cell physiology
|
J:97513
|
Ncf1tm1Shl/Ncf1tm1Shl
(involves: 129S2/SvPas * C57BL/6J)
|
decreased vasoconstriction
|
J:120187
|
Ncf1tm1Shl/Ncf1tm1Shl
(B6.129S2-Ncf1tm1Shl)
|
abnormal vascular smooth muscle physiology
|
J:111142
|
abnormal vascular wound healing
|
J:142617
|
Ndptm1Lex/Y
(involves: 129S5/SvEvBrd)
|
increased vascular permeability
|
J:154863
|
Ndptm1Lex/Ndptm1Lex
(involves: 129S5/SvEvBrd)
|
increased vascular permeability
|
J:154863
|
Nfil3tm1.1(KOMP)Vlcg/Nfil3tm1.1(KOMP)Vlcg
(C57BL/6N-Nfil3tm1.1(KOMP)Vlcg/Ucd)
|
cornea vascularization
|
J:211773
|
Ngftm1.1Blhe/Ngf+
(B6.Cg-Ngftm1.1Blhe)
|
abnormal vascular endothelial cell physiology
|
J:190893
|
increased vascular permeability
|
J:190893
|
Ngfrtm1Jae/Ngfrtm1Jae
(B6.129S4-Ngfrtm1Jae)
|
abnormal vascular wound healing
|
J:109753
|
Nodaltm1b(EUCOMM)Wtsi/Nodal+
(C57BL/6N-Nodaltm1b(EUCOMM)Wtsi/H)
|
cornea vascularization
|
J:211773
|
Nos1tm1Plh/Nos1tm1Plh
(involves: 129S4/SvJae)
|
abnormal vascular wound healing
|
J:120009
|
Nos1tm1Plh/Nos1tm1Plh
(B6.129S4-Nos1tm1Plh)
|
abnormal blood-brain barrier function
|
J:150557
|
decreased susceptibility to induced choroidal neovascularization
|
J:106207
|
Nos1tm1Plh/Nos1tm1Plh Nos2tm1Mrl/Nos2tm1Mrl Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6)
|
abnormal vascular endothelial cell physiology
|
J:155090
|
abnormal vascular wound healing
|
J:155090
|
Nos2tm1Lau/Nos2tm1Lau
(B6.129P2-Nos2tm1Lau)
|
decreased susceptibility to induced choroidal neovascularization
|
J:106207
|
Nos2tm1Mrl/Nos2tm1Mrl
(involves: 129S7/SvEvBrd)
|
abnormal induced retina neovascularization
|
J:112024
|
Nos3tm1Gdk/Nos3tm1Gdk
(involves: 129P2/OlaHsd * C57BL/6)
|
increased vasoconstriction
|
J:46061
|
Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae)
|
abnormal vasodilation
|
J:112419
|
decreased vasodilation
|
J:28778
|
increased vasoconstriction
|
J:57624
|
Nos3tm1Plh/Nos3tm1Plh
(B6.129S4-Nos3tm1Plh)
|
abnormal induced retina neovascularization
|
J:106207
|
abnormal vascular endothelial cell physiology
|
J:155090
|
Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae * C57BL/6)
|
abnormal blood vessel physiology
|
J:108540,
J:75645
|
abnormal induced retina neovascularization
|
J:66540
|
abnormal vascular wound healing
|
J:119617,
J:139343
|
Nos3tm1Plh/Nos3tm1Plh Ptgs1tm1Unc/Ptgs1tm1Unc
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal blood vessel physiology
|
J:108540
|
Nos3tm1Unc/Nos3+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased vasodilation
|
J:54772
|
Nos3tm1Unc/Nos3tm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased vascular permeability
|
J:113106
|
Nos3tm1Unc/Nos3tm1Unc
(involves: 129P2/OlaHsd)
|
decreased vasodilation
|
J:103153
|
Nos3tm1Unc/Nos3tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal vasodilation
|
J:54772
|
increased vasoconstriction
|
J:54772
|
Nos3tm1Unc/Nos3tm1Unc
(B6.129P2-Nos3tm1Unc)
|
abnormal blood-brain barrier function
|
J:150557
|
Nos3tm2.1Plh/Nos3tm2.1Plh
(involves: 129S4/SvJae * C57BL/6)
|
decreased vasodilation
|
J:198075
|
Nostrintm1.1Oess/Nostrintm1.1Oess
(B6.129S2(Cg)-Nostrintm1.1Oess)
|
abnormal induced retina neovascularization
|
J:188414
|
decreased vascular endothelial cell proliferation
|
J:188414
|
Nostrintm1Oess/Nostrintm1Oess Tg(Tek-cre)12Flv/0
(involves: 129S2/SvPas * C3H * C57BL/6)
|
decreased vascular endothelial cell proliferation
|
J:188414
|
Notch1tm2Rko/Notch1tm3(cre)Rko
(involves: 129X1/SvJ * C57BL/6)
|
cornea vascularization
|
J:171829
|
Nox1tm1Cyn/Y
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vasodilation
|
J:116837
|
Nox1tm1Kkr/Y
(B6.129X1-Nox1tm1Kkr)
|
abnormal blood vessel physiology
|
J:105425
|
Nox4tm1.1Hwsc/Nox4tm1.1Hwsc
(involves: 129P2/OlaHsd * C57BL/6)
|
enhanced blood-brain barrier function
|
J:166948
|
Npr1tm1Gar/Npr1tm1Gar
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal vasodilation
|
J:42893
|
Npr1tm1Kuhn/Npr1tm1Kuhn Tg(Tagln-cre)1Her/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal vasodilation
|
J:76460
|
Npy1rtm1Tped/Npy1rtm1Tped
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal vasoconstriction
|
J:47972
|
Nr1h3tm1Djm/Nr1h3tm1Djm
(involves: 129S6/SvEvTac * C57BL/6)
|
increased vascular permeability
|
J:158168
|
Nr3c1tm1.1Jaci/Nr3c1tm1.1Jaci Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6 * FVB/N)
|
pathological neovascularization
|
J:201995
|
Nr3c1tm2.1Gsc/Nr3c1+
(B6.129P2-Nr3c1tm2.1Gsc)
|
abnormal blood-brain barrier function
|
J:137157
|
Nr3c2tm1.1Ics/Nr3c2tm1.1Ics Tg(Acta2-cre/ERT2)#Pcn/0
(involves: 129S2/SvPas * FVB/N)
|
abnormal vasoconstriction
|
J:193438
|
abnormal vasodilation
|
J:193438
|
decreased vasoconstriction
|
J:193438
|
increased vasoconstriction
|
J:193438
|
increased vasodilation
|
J:193438
|
Nr4a1tm1Jmi/Nr4a1tm1Jmi
(involves: 129S2/SvPas)
|
abnormal vascular permeability
|
J:205553
|
Nrarptm1Vlcg/Nrarptm1Vlcg
(involves: C57BL/6J)
|
decreased vascular endothelial cell proliferation
|
J:144980
|
Nrarptm1Vlcg/Nrarptm1Vlcg
(involves: 129 * C57BL/6)
|
abnormal induced retina neovascularization
|
J:177797
|
Nrp1tm1.1Izac/Nrp1tm1.1Izac
(involves: 129S2/SvPas * C57BL/6)
|
abnormal induced retina neovascularization
|
J:208348
|
Nt5etm1Lft/Nt5etm1Lft
(involves: 129S1/Sv * C57BL/6)
|
increased vascular permeability
|
J:94697
|
Nus1tm1Wcsa/Nus1tm1Wcsa Tg(Cdh5-cre/ERT2)1Rha/0
(Not Specified)
|
increased vascular endothelial cell apoptosis
|
J:230506
|
Nus1tm1Wcsa/Nus1tm1Wcsa Tg(Tek-cre)12Flv/0
(involves: C3H * C57BL/6)
|
abnormal vascular endothelial cell physiology
|
J:230506
|
Odad2b2b643Clo/Odad2b2b643Clo
(C57BL/6J-Odad2b2b643Clo)
|
abnormal blood vessel physiology
|
J:206685
|
Optctm1.1Pnb/Optctm1.1Pnb
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal induced retina neovascularization
|
J:191528
|
Or51e1tm1Jplu/Or51e1tm1Jplu
(C57BL/6N-Or51e1tm1Jplu/J)
|
abnormal vascular smooth muscle physiology
|
J:346436
|
decreased vasoconstriction
|
J:346436
|
increased vasoconstriction
|
J:346436
|
increased vasodilation
|
J:346436
|
Or51e2tm1Mom/Or51e2tm1Mom
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal carotid body physiology
|
J:241915
|
Or51e2tm3.1Mom/Or51e2tm3.1Mom Thtm1(cre)Te/?
(involves: 129X1/SvJ * C57BL/6)
|
abnormal type I cell of carotid body physiology
|
J:350385
|
P2rx2tm1Ckn/P2rx2tm1Ckn
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal carotid body physiology
|
J:86890
|
P2rx2tm1Ckn/P2rx2tm1Ckn P2rx3tm1Ckn/P2rx3tm1Ckn
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal carotid body physiology
|
J:86890
|
P2rx4tm1Ando/P2rx4tm1Ando
(Not Specified)
|
abnormal blood vessel physiology
|
J:104459
|
abnormal vascular endothelial cell physiology
|
J:104459
|
abnormal vasodilation
|
J:104459
|
P2ry2tm1c(EUCOMM)Hmgu/P2ry2tm1c(EUCOMM)Hmgu Tg(Tek-icre/ERT2)1Soff/0
(B6N.Cg-P2ry2tm1c(EUCOMM)Hmgu Tg(Tek-icre/ERT2)1Soff)
|
decreased vasodilation
|
J:224523
|
P2ry6tm1.1Brob/P2ry6tm1.1Brob
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
decreased vasoconstriction
|
J:169742
|
decreased vasodilation
|
J:169742
|
Palmdtm1.2Kili/Palmdtm1.2Kili
(involves: C57BL/6N)
|
abnormal vascular endothelial cell physiology
|
J:320912
|
Pappatm1Lex/Pappatm1Lex Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S5/SvEvBrd * C57BL/6 * CBA)
|
abnormal vascular wound healing
|
J:201775
|
Pax6em1(IMPC)Mbp/Pax6+
(C57BL/6N-Pax6em1(IMPC)Mbp/MbpMmucd)
|
cornea vascularization
|
J:211773
|
Pax6Sey-Neu/Pax6+
(involves: 102 * C3H)
|
cornea vascularization
|
J:114973,
J:83026
|
Pax6Sey/Pax6Sey
(C.Cg-Pax6Sey)
|
cornea vascularization
|
J:119940
|
Pdctm1Luhe/Pdctm1Luhe
(B6.129P2-Pdctm1Luhe)
|
decreased vasodilation
|
J:155373
|
increased vasoconstriction
|
J:155373
|
Pdgfbtm3.1Cbet/Pdgfbtm3.1Cbet
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
impaired blood-brain barrier function
|
J:166532
|
Pdgfrbredeye/Pdgfrbredeye
(C3N.C-Pdgfrbredeye)
|
increased vascular permeability
|
J:199483
|
Pdgfrbtm14(Pdgfrb)Sor/Pdgfrb+ Tg(Tagln-cre)1Her/0
(involves: 129S4/SvJaeSor * C57BL/6 * SJL)
|
increased vascular smooth muscle cell proliferation
|
J:173602
|
Pdpntm2.1Mlkn/Pdpntm2.1Mlkn Tg(CAG-cre/Esr1*)5Amc/0
(involves: C57BL/6 * CBA)
|
increased vascular permeability
|
J:205423
|
Pecam1Gt(OST16303)Lex/Pecam1Gt(OST16303)Lex
(B6.129S5-Pecam1Gt(OST16303)Lex)
|
decreased vasodilation
|
J:104082
|
Pecam1Gt(OST16303)Lex/Pecam1Gt(OST16303)Lex
(B6.129S-Pecam1Gt(OST16303)Lex/J)
|
abnormal vasodilation
|
J:114343
|
decreased vasodilation
|
J:114343
|
Pecam1tm1Mak/Pecam1tm1Mak
(B6.129P2-Pecam1tm1Mak)
|
increased vascular permeability
|
J:95226
|
Pex1tm1.1Hrw/Pex1tm1.1Hrw
(involves: C57BL/6NTac)
|
phlebitis
|
J:278655
|
Pfn1tm1Foxp/Pfn1tm1Foxp Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * C57BL/6NTac * SJL)
|
abnormal vascular wound healing
|
J:193938
|
Pgftm1Pec/Pgftm1Pec
(either: (involves: 129X1/SvJ * C57BL/6J) or (involves: 129X1/SvJ * Swiss))
|
abnormal vascular permeability
|
J:77877
|
Pgftm1Pec/Pgftm1Pec
(involves: 129)
|
abnormal vascular permeability
|
J:77877
|
Pgftm1Pec/Pgftm1Pec
(Not Specified)
|
cornea vascularization
|
J:114973
|
Pgrtm1.1Mlia/Pgrtm1.1Mlia Tg(Cdh5-cre)7Mlia/0
(involves: 129X1/SvJ * FVB/N)
|
abnormal vascular permeability
|
J:205553
|
Pgrtm1Bwo/Pgrtm1Bwo
(involves: 129S7/SvEvBrd)
|
abnormal vascular wound healing
|
J:118403
|
Piezo1tm1a(KOMP)Wtsi/Piezo1tm1a(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
abnormal vascular endothelial cell physiology
|
J:217082
|
Piptm1Myal/Piptm1Myal
(involves: 129S/SvEv * C57BL/6)
|
arteritis
|
J:202016
|
Plac8tm1Bhk/Plac8tm1Bhk
(129S/SvEv-Plac8tm1Bhk)
|
increased vascular permeability
|
J:145277
|
Plattm1Mlg/Plattm1Mlg
(involves: 129S2/SvPas * C57BL/6)
|
decreased susceptibility to induced choroidal neovascularization
|
J:82604
|
Plautm1Mlg/Plautm1Mlg
(involves: 129S2/SvPas * C57BL/6)
|
decreased susceptibility to induced choroidal neovascularization
|
J:82604
|
Plekha5em1(IMPC)Tcp/Plekha5em1(IMPC)Tcp
(C57BL/6NCrl-Plekha5em1(IMPC)Tcp/Tcp)
|
cornea vascularization
|
J:211773
|
Plekhg5tm1Jbar/Plekhg5tm1Jbar Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * SJL)
|
increased vascular permeability
|
J:195233
|
Plgtm1Dco/Plgtm1Dco
(involves: 129S2/SvPas * C57BL/6)
|
decreased susceptibility to induced choroidal neovascularization
|
J:82604
|
Plgtm1Jld/Plgtm1Jld
(B6.129P2-Plgtm1Jld)
|
cornea vascularization
|
J:46096
|
Plod3tm1Rmyl/Plod3tm1Rmyl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased vasodilation
|
J:106510
|
Plod3tm2Rmyl/Plod3tm2Rmyl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased vasodilation
|
J:106510
|
Plvaptm1.1Rvst/Plvaptm1.1Rvst Tg(Cdh5-cre)1Spe/0
(involves: 129S1/SvImJ * 129S4/SvJae * C57BL/6 * C57BL/6J)
|
increased vascular permeability
|
J:191046
|
Plvaptm1.1Rvst/Plvaptm1.1Rvst Tg(Tek-cre)12Flv/0
(involves: 129S4/SvJae * C3H * C57BL/6)
|
increased vascular permeability
|
J:191046
|
Plvaptm1.2Rvst/Plvaptm1.2Rvst
(involves: 129S4/SvJae * BALB/c * C57BL/6 * SJL)
|
increased vascular permeability
|
J:191046
|
Plxnd1tm1Ddg/Plxnd1tm1.1Tmj Tg(CAG-cre/Esr1*)1Egwa/0
(involves: 129S/SvEv * C57BL/6 * DBA/2)
|
abnormal induced retina neovascularization
|
J:173943
|
Podxltm2Kmn/Podxltm2Kmn Tg(Cdh5-cre)7Mlia/0
(B6.Cg-Podxltm2Kmn Tg(Cdh5-cre)7Mlia)
|
decreased lung endothelial cell adhesion
|
J:223453
|
increased lung endothelial cell adhesion
|
J:223453
|
increased vascular permeability
|
J:223453
|
Poldip2Gt(IST12080D9)Tigm/Poldip2+
(involves: C57BL/6N)
|
abnormal vasoconstriction
|
J:211022
|
abnormal vasodilation
|
J:211022
|
Pomt1Gt(OST194127)Lex/Pomt1+
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased vasodilation
|
J:103485
|
Ppargtm2Rev/Ppargtm2Rev Tg(Tek-cre)12Flv/?
(B6.Cg-Ppargtm2Rev Tg(Tek-cre)12Flv)
|
abnormal vascular endothelial cell physiology
|
J:154216
|
abnormal vasodilation
|
J:154216
|
Ppcd1/+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
cornea vascularization
|
J:164007
|
Ppcd1/+
(D2.129-Ppcd1)
|
cornea vascularization
|
J:164007
|
Ppm1atm1.2Lavi/Ppm1atm1.2Lavi
(B.129(Cg)-Ppm1atm1.2Lavi)
|
pathological neovascularization
|
J:216372
|
Ppp1r12aem1Sfsh/Ppp1r12a+ Tg(Myh11-icre/ERT2)1Soff/0
(involves: C57BL/6J * FVB/N)
|
abnormal blood vessel physiology
|
J:230106
|
Ppp1r13lwoe2/Ppp1r13lwoe2
(involves: 129X1/SvJ * C57BL/6)
|
cornea vascularization
|
J:190557
|
Ppp1r14aem1Gpt/Ppp1r14a+
(involves: C57BL/6J)
|
decreased vasoconstriction
|
J:290992
|
Ppp1r14aem1Gpt/Ppp1r14aem1Gpt
(involves: C57BL/6J)
|
decreased vasoconstriction
|
J:290992
|
Prkcbtm1Tara/Prkcbtm1Tara
(B6.Cg-Prkcbtm1Tara)
|
abnormal vascular wound healing
|
J:106870
|
Prkg1tm1.1Arte/Prkg1tm1.1Arte
(C57BL/6-Prkg1tm1.1Arte)
|
decreased vasodilation
|
J:181180
|
Prkg1tm1Hfm/Prkg1tm1Hfm
(Not Specified)
|
abnormal vascular smooth muscle physiology
|
J:48058
|
Prkg1tm1Meme/Prkg1tm1Meme
(involves: 129S/SvEv)
|
abnormal blood vessel physiology
|
J:134634
|
decreased vasodilation
|
J:134634
|
Prkg1tm2.1Naw/Prkg1tm2.1Naw
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vascular smooth muscle physiology
|
J:134928
|
Prmt2tm1Enbl/Prmt2tm1Enbl
(involves: 129S2/SvPas)
|
abnormal vascular wound healing
|
J:111352
|
Pros1tm1.2Grl/Pros1+
(involves: 129S1/SvImJ * FVB/N)
|
increased vascular permeability
|
J:198769
|
Pros1tm1.2Grl/Pros1tm1.2Grl
(involves: 129S1/SvImJ * FVB/N)
|
increased vascular permeability
|
J:198769
|
Pros1tm1Grl/Pros1tm1Grl Tg(Tagln-cre)1Her/0
(involves: 129S1/SvImJ * C57BL/6 * SJL)
|
increased vascular permeability
|
J:198769
|
Prph2Rd2/Prph2Rd2
(O20/A-Prph2Rd2)
|
retina neovascularization
|
J:6432
|
Prss34tm1.1Hkar/Prss34tm1.1Hkar
(involves: C57BL/6)
|
decreased vascular permeability
|
J:238924
|
Prss57tm1.1Gne/Prss57tm1.1Gne
(C57BL/6N-Prss57tm1.1Gne)
|
decreased vascular permeability
|
J:301479
|
Psen1tm1Bdes/Psen1+ Psen2tm1Bdes/Psen2tm1Bdes
(involves: 129P2/OlaHsd)
|
arteritis
|
J:91235
|
Psen1tm1Hko/Psen1tm1Hko
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased vasodilation
|
J:84418
|
Ptafrtm1Eit/Ptafrtm1Eit
(involves: C57BL/6)
|
abnormal blood-brain barrier function
|
J:104293
|
abnormal vascular endothelial cell physiology
|
J:104293
|
Ptch1tm1Mps/Ptch1+ Ptch2tm1Pmc/Ptch2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
telangiectasia
|
J:112118
|
Ptgdrtm1Dgen/Ptgdr+
(B6.129P2-Ptgdrtm1Dgen)
|
decreased vasodilation
|
J:109107
|
increased vasodilation
|
J:109107
|
Ptgdrtm1Dgen/Ptgdrtm1Dgen
(B6.129P2-Ptgdrtm1Dgen)
|
decreased vasodilation
|
J:109107
|
Ptgdrtm1Sna/Ptgdrtm1Sna
(B6.129P2-Ptgdrtm1Sna/Sna)
|
abnormal vascular permeability
|
J:197334
|
Ptger2tm1Brey/Ptger2tm1Brey
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal vasodilation
|
J:53646
|
Ptger2tm1Brey/Ptger2tm1Brey
(involves: 129S6/SvEvTac)
|
abnormal vasodilation
|
J:78902
|
increased vasoconstriction
|
J:78902
|
Ptger3tm1Cof/Ptger3tm1Cof
(involves: 129P2/OlaHsd)
|
increased vasodilation
|
J:77409
|
Ptgestm1.1Gaf/Ptgestm1.1Gaf Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129 * C57BL/6)
|
abnormal vascular wound healing
|
J:210141
|
Ptgestm1.1Gaf/Ptgestm1.1Gaf Tg(Tagln-cre)1Her/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal vascular wound healing
|
J:210141
|
Ptgestm1.1Gaf/Ptgestm1.1Gaf Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal vascular wound healing
|
J:210141
|
Ptgirtm1Sna/Ptgirtm1Sna
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal blood vessel physiology
|
J:79049
|
Ptgs2tm1Jed/Ptgs2tm1Jed
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased vascular permeability
|
J:118171
|
Ptgs2tm1Unc/Ptgs2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal induced retina neovascularization
|
J:109021
|
Ptgs2tm2.1(Ptgs1)Fun/Ptgs2tm2.1(Ptgs1)Fun
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB)
|
decreased vascular permeability
|
J:118171
|
Ptk2tm1.1Guan/Ptk2tm1.1Guan Tg(Tek-cre)12Flv/0
(involves: 129P2/OlaHsd * C3H * C57BL/6)
|
increased vascular permeability
|
J:162690
|
Ptk2tm2.1Guan/Ptk2tm1.1Guan Tg(Tek-cre)12Flv/0
(involves: 129P2/OlaHsd * C3H * C57BL/6 * FVB/N)
|
increased vascular permeability
|
J:162690
|
Ptk2btm1Okig/Ptk2btm1Okig
(involves: C57BL/6)
|
decreased vasodilation
|
J:139849
|
Ptprmtm1Mfbg/Ptprmtm1Mfbg
(FVB.129P2-Ptprmtm1Mfbg)
|
decreased vasodilation
|
J:97057
|
Rac2tm1Mddw/Rac2tm1Mddw
(involves: 129S/SvEv)
|
decreased vascular endothelial cell proliferation
|
J:131305
|
Rag1tm1Mom/Rag1tm1Mom
(B6.129S7-Rag1tm1Mom)
|
decreased vascular permeability
|
J:78613
|
Ramp1tm1.1Tsuj/Ramp1tm1.1Tsuj
(involves: 129S2/SvPas * C57BL/6)
|
decreased vasodilation
|
J:125974
|
Ramp2tm1.1Tash/Ramp2+
(involves: C57BL/6)
|
impaired blood-brain barrier function
|
J:130931
|
increased vascular permeability
|
J:130931
|
Rcn2tm1b(KOMP)Wtsi/Rcn2tm1b(KOMP)Wtsi
(involves: C3H * C57BL/6 * C57BL/6N)
|
abnormal blood vessel physiology
|
J:280163
|
Relatm2.1Gho/Relatm2.1Gho Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
(involves: 129S2/SvPas * 129S6/SvEvTac)
|
cornea vascularization
|
J:163663
|
Relbtm1Brv/Relbtm1Brv
(either: (involves: 129S2/SvPas) or (involves: C57BL/6) or (involves: 129S2/SvPas * C57BL/6))
|
pathological neovascularization
|
J:63950
|
Ren1tm1.2Sig/Ren1tm1.2Sig
(involves: C57BL/6J)
|
decreased vasoconstriction
|
J:169129
|
Rfxapem1(IMPC)J/Rfxapem1(IMPC)J
(C57BL/6NJ-Rfxapem1(IMPC)J/Mmjax)
|
cornea vascularization
|
J:211773
|
Rgs2tm1.1Kjb/Rgs2tm1.1Kjb Tg(Tek-cre/ERT2)1Arnd/?
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased vasodilation
|
J:184284
|
Rgs2tm1Pngr/Rgs2tm1Pngr
(involves: C57BL/6J)
|
abnormal blood vessel physiology
|
J:86774
|
Rgs2tm1Pngr/Rgs2tm1Pngr
(B6.129P2-Rgs2tm1Pngr)
|
decreased vasodilation
|
J:184284
|
increased vasoconstriction
|
J:184284
|
rnv6/rnv6
(B6.Cg-Jak3+ rnv6/BocJ)
|
retina neovascularization
|
J:352922
|
rnv7/rnv7
(STOCK-rnv7/Boc)
|
retina neovascularization
|
J:353654
|
rnv7/rnv7
(B6.Cg-rnv7/Boc)
|
retina neovascularization
|
J:353654
|
rnv8/rnv8
(B6.Cg-rnv8/BocJ)
|
choroidal neovascularization
|
J:354131
|
retina neovascularization
|
J:354131
|
rnv9/rnv9
(B6.Cg-rnv9/Boc)
|
retina neovascularization
|
J:354548
|
Robo4tm1Kzh/Robo4tm1Kzh
(involves: C57BL/6)
|
abnormal vascular permeability
|
J:133680
|
pathological neovascularization
|
J:133680
|
Robo4tm1Kzh/Robo4tm1Kzh
(Not Specified)
|
increased vasodilation
|
J:294754
|
Rock1tm1Liao/Rock1+
(C57BL/6-Rock1tm1Liao)
|
abnormal vascular endothelial cell physiology
|
J:135152
|
abnormal vascular wound healing
|
J:135152
|
Rock2Gt(OST440776)Lex/Rock2Gt(OST440776)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
retina neovascularization
|
J:186058
|
Rock2tm1.1Itl/Rock2+ Tg(Tagln-cre)1Her/0
(B6.Cg-Rock2tm1.1Itl Tg(Tagln-cre)1Her)
|
abnormal vascular smooth muscle physiology
|
J:222206
|
decreased vascular smooth muscle cell proliferation
|
J:222206
|
Rorasg/Rorasg
(involves: C57BL/6)
|
abnormal vasoconstriction
|
J:109735
|
abnormal vasodilation
|
J:109735
|
RpgrRd9/Y
(C57BL/6-RpgrRd9)
|
telangiectasia
|
J:237833
|
RpgrRd9/RpgrRd9
(C57BL/6-RpgrRd9)
|
telangiectasia
|
J:237833
|
Rpl24Bst/Rpl24+
(involves: C57BLKS)
|
pathological neovascularization
|
J:60921
|
retina neovascularization
|
J:60921
|
Rr249tm1.1Ebres/Rr249tm1.1Ebres
(involves: 129 * BALB/cJ * C57BL/6)
|
increased vascular permeability
|
J:191756
|
RrasGt(OST24882)Lex/RrasGt(OST24882)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal vascular wound healing
|
J:104130
|
S1pr1tm1Rlp/S1pr1tm1Rlp
(involves: 129S6/SvEvTac)
|
increased vascular endothelial cell apoptosis
|
J:189010
|
S100a1tm1Jhh/S100a1tm1Jhh
(involves: 129S1/Sv * C57BL/6)
|
decreased vasodilation
|
J:230300
|
Scarb1tm1Kri/Scarb1tm1Kri
(involves: 129S2/SvPas)
|
abnormal vascular wound healing
|
J:118063
|
Scpep1tm1Jomm/Scpep1tm1Jomm
(involves: 129S/SvEvBrd * C57BL/6)
|
abnormal vascular wound healing
|
J:158052
|
Sdc2tm1c(KOMP)Wtsi/Sdc2tm1c(KOMP)Wtsi Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/0
(involves: C57BL/6J * C57BL/6N * CBA)
|
decreased vascular endothelial cell proliferation
|
J:276769
|
Sdc2tm1d(KOMP)Wtsi/Sdc2tm1d(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
abnormal vascular endothelial cell physiology
|
J:276769
|
decreased vascular endothelial cell proliferation
|
J:276769
|
Sdhdtm1Jlob/Sdhd+
(involves: 129X1/SvJ)
|
abnormal carotid body physiology
|
J:95252
|
abnormal type I cell of carotid body physiology
|
J:95252
|
Serpind1tm1Moto/Serpind1+
(B6.Cg-Serpind1tm1Moto)
|
abnormal vascular wound healing
|
J:122173
|
Serping1Gt1Aed/Serping1+
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased vascular permeability
|
J:76090
|
Serping1Gt1Aed/Serping1Gt1Aed
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased vascular permeability
|
J:76090
|
Sgcgtm1Mcn/Sgcgtm1Mcn
(involves: 129X1/SvJ * C57BL/6)
|
coronary artery spasm
|
J:88456
|
Sh3pxd2bnee/Sh3pxd2bnee
(B10.Cg-H2h4 Sh3pxd2bnee/GrsrJ)
|
cornea vascularization
|
J:262132
|
Shc1tm1Pgp/Shc1tm1Pgp
(involves: 129)
|
increased vasodilation
|
J:81977
|
Sirt6tm1Fwa/Sirt6tm1Fwa
(involves: 129S6/SvEvTac * BALB/cJ)
|
cornea vascularization
|
J:247143
|
Slc4a5tvrm77/Slc4a5tvrm77
(C57BL/6J-Slc4a5tvrm77/Pjn)
|
retina neovascularization
|
J:321062
|
Slc4a7Gt(40G1)Cmhd/Slc4a7Gt(40G1)Cmhd
(B6.129-Slc4a7Gt(40G1)Cmhd)
|
abnormal vascular endothelial cell physiology
|
J:189470
|
abnormal vascular smooth muscle physiology
|
J:189470
|
abnormal vasoconstriction
|
J:189470
|
decreased vasodilation
|
J:189470
|
Smad3tm1Cxd/Smad3tm1Cxd
(B6.129S6-Smad3tm1Cxd)
|
abnormal vascular wound healing
|
J:108527
|
Smad6tm1Glvn/Smad6tm1Glvn
(involves: 129S6/SvEvTac * BALB/cByJ)
|
abnormal blood vessel physiology
|
J:60214
|
decreased vasodilation
|
J:60214
|
Smad7Gt(YHC053)Byg/Smad7+ Tbx1tm1Bld/Tbx1+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J)
|
increased vascular smooth muscle cell proliferation
|
J:212881
|
Smtntm1Gve/Smtntm1Gve
(involves: 129/Sv * C57BL/6)
|
decreased vasoconstriction
|
J:158046
|
Smtntm2Gve/Smtntm2Gve
(B6.129-Smtntm2Gve)
|
abnormal blood vessel physiology
|
J:158046
|
decreased vasoconstriction
|
J:158046
|
Smtnl1tm1Tajh/Smtnl1tm1Tajh
(129S6.129P2-Smtnl1tm1Tajh)
|
abnormal blood vessel physiology
|
J:136573
|
decreased vasoconstriction
|
J:136573
|
increased vasodilation
|
J:136573
|
Smyd3em1Yzzh/Smyd3em1Yzzh
(C57BL/6-Smyd3em1Yzzh)
|
abnormal vasodilation
|
J:296379
|
Sorl1tm1Bujo/Sorl1tm1Bujo
(involves: 129/Sv * C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:140878
|
abnormal vascular wound healing
|
J:140878
|
Sox17tm2Sjm/Sox17tm2Sjm Tg(Cdh5-cre/ERT2)1Rha/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased vascular permeability
|
J:234137
|
Sox18Ra-Op/Sox18Ra-Op
(B6D2-Sox18Ra-Op/J)
|
abnormal vascular endothelial cell physiology
|
J:150211
|
Sphk1tm1.1Cgh/Sphk1tm2Cgh Sphk2tm1.1Cgh/Sphk2tm1.1Cgh Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
increased vascular permeability
|
J:205423
|
Spns2tm1a(KOMP)Wtsi/Spns2tm1a(KOMP)Wtsi
(B6JTyr;B6N-Spns2tm1a(KOMP)Wtsi/Wtsi)
|
cornea vascularization
|
J:165965
|
Spns2tm1a(KOMP)Wtsi/Spns2tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
cornea vascularization
|
J:213427
|
Spns2tm1b(KOMP)Wtsi/Spns2tm1b(KOMP)Wtsi
(B6Brd;B6Dnk;B6N-Tyrc-Brd Spns2tm1b(KOMP)Wtsi/WtsiH)
|
cornea vascularization
|
J:211773
|
Spp1tm1Blh/Spp1tm1Blh
(involves: 129S6/SvEvTac * Black Swiss)
|
abnormal blood vessel physiology
|
J:103050
|
abnormal vascular wound healing
|
J:103050
|
abnormal vasodilation
|
J:103050
|
Ssbp2tm1Lana/Ssbp2tm1Lana
(involves: 129S/SvEv * C57BL/6)
|
arteritis
|
J:162035
|
Stk35em1(IMPC)J/Stk35em1(IMPC)J
(C57BL/6N-Stk35em1(IMPC)J/J)
|
cornea vascularization
|
J:211773
|
Stk39tm2.1Arte/Stk39tm2.1Arte
(involves: C57BL/6J)
|
decreased vasoconstriction
|
J:224087
|
Stmn1tm1Wed/Stmn1tm1Wed
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal vascular wound healing
|
J:144737
|
Syde1tm1.1Hwch/Syde1tm1.1Hwch
(involves: C57BL/6J)
|
increased vascular permeability
|
J:241798
|
Tacr1tm1Nge/Tacr1tm1Nge
(involves: 129S4/SvJae * C57BL)
|
decreased vascular permeability
|
J:84660
|
Tbx1tm1Bld/Tbx1+
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased vascular smooth muscle cell proliferation
|
J:212881
|
Tbxa2rtm1Cof/Tbxa2rtm1Cof
(C.129P2(B6)-Tbxa2rtm1Cof)
|
abnormal blood vessel physiology
|
J:79049
|
Tcra-Jtm1Tgi/Tcra-Jtm1Tgi
(B6.129-Tcra-Jtm1Tgi)
|
decreased susceptibility to induced choroidal neovascularization
|
J:138197
|
Tfap2bem1Fenli/Tfap2bem1Fenli
(involves: C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:278067
|
Tfap2btm1Rbu/Tfap2btm2Will H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J)
|
cornea vascularization
|
J:234170
|
Tg(ACTB-EGFP,-Kcnj8*)1Wco/0 Tg(Tek-cre)12Flv/0
(involves: C3H * C57BL/6 * FVB/N)
|
abnormal blood vessel physiology
|
J:134852
|
Tg(ACTB-EGFP,-Kcnj8*G343D)9Nich/0 Tg(Myh11-icre/ERT2)1Soff/0
(involves: C57BL/6 * CBA * FVB/N)
|
abnormal vascular smooth muscle physiology
|
J:202037
|
decreased vasoconstriction
|
J:202037
|
Tg(Apcs-Lep)1Yog/?
(involves: C57BL/6 * DBA/2)
|
retina neovascularization
|
J:92072
|
Tg(APPswe,PSEN1dE9)85Dbo/0
(WSB.Cg-Tg(APPswe,PSEN1dE9)85Dbo/How)
|
impaired blood-brain barrier function
|
J:276728
|
Tg(BEST1-HTRA1)#Ybf/0
(involves: C57BL/6J)
|
choroidal neovascularization
|
J:175227
|
Tg(CAG-APPL1)#Ymli/0
(involves: C57BL/6 * CBA)
|
abnormal vasodilation
|
J:189487
|
decreased vasoconstriction
|
J:189487
|
increased vasodilation
|
J:189487
|
Tg(CAG-cre/Esr1*)5Amc/0 Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
retina neovascularization
|
J:221181
|
Tg(CMV-IgkvaD11)BCat/Tg(CMV-IgkvaD11)BCat
(involves: C57BL/6 * SJL)
|
impaired blood-brain barrier function
|
J:212312
|
Tg(CNN1)#Jomm/0
(involves: FVB/N)
|
abnormal vascular wound healing
|
J:191843
|
Tg(Edn1-NOS3)22Yky/0
(involves: C57BL/6 * DBA/2)
|
abnormal blood vessel physiology
|
J:81132
|
decreased vasodilation
|
J:81132
|
Tg(Gfap-TGFB1)64Lms/0 Zbtb20Tg(PDGFB-APPSwInd)20Lms/0
(involves: BALB/c * C57BL/6 * DBA/2 * SJL)
|
decreased vasodilation
|
J:167619
|
Tg(Gfap-TK)7.1Mvs/0
(involves: C57BL/10 * CBA * CFLP)
|
abnormal blood-brain barrier function
|
J:113202
|
Tg(IGFBP1)2Miel/0
(involves: C57BL * CBA)
|
decreased vasoconstriction
|
J:84652
|
Tg(K18-ACE2)2Prlmn/0
(B6.Cg-Tg(K18-ACE2)2Prlmn/J)
|
blood vessel inflammation
|
J:300960
|
Tg(KRT5-TGFB1)F2020Xjw/0
(involves: C57BL/6 * DBA/2 * ICR)
|
pathological neovascularization
|
J:90118
|
Tg(KRT14-Pgf)1Odo/0
(involves: C57BL/6 * DBA/2)
|
increased vascular permeability
|
J:77722
|
Tg(KRT14-Vegfa)3Dtm/0
(FVB/N-Tg(KRT14-Vegfa)3Dtm)
|
increased vascular permeability
|
J:104245,
J:92643
|
Tg(Lck-Tnfsf4)1Nish/0
(B6.Cg-Tg(Lck-Tnfsf4)1Nish)
|
increased vasoconstriction
|
J:194882
|
Tg(LIPG)1Tq/0
(involves: C57BL/6)
|
abnormal vascular endothelial cell physiology
|
J:95158
|
Tg(Mpz-RAF1/ESR1)A668Ayld/0
(involves: C57BL/6J * CBA/J)
|
abnormal blood vessel physiology
|
J:182703
|
Tg(Nes-cre)1Kln/0 Wnt7atm1Amc/Wnt7atm1Amc Wnt7btm1Parr/Wnt7btm2Amc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal blood-brain barrier function
|
J:142352
|
Tg(NES/TK-PDGFB,-lacZ)310Kfn/0
(B6.Cg-Tg(NES/TK-PDGFB,-lacZ)310Kfn)
|
abnormal blood vessel physiology
|
J:189829
|
Tg(Notch3*R169C)88Bbb/0
(involves: FVB/N)
|
abnormal blood vessel physiology
|
J:156682
|
abnormal vascular smooth muscle physiology
|
J:220006
|
decreased vasoconstriction
|
J:156682,
J:220006
|
Tg(Prnp-APPSweArc)#Rmni/0
(involves: C57BL/6 * DBA/2)
|
abnormal vasodilation
|
J:239408
|
Tg(RHO-VEGFA)V-6Camp/0
(involves: C57BL/6J)
|
increased vascular permeability
|
J:41411
|
retina neovascularization
|
J:41411,
J:138010
|
Tg(RNU6-RNAi:Mpp5)13Wij/0 Tg(rx3-icre)1Mjam/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
increased vascular permeability
|
J:178056
|
Tg(Tagln-Ager)#Yon/?
(C57BL/6-Tg(Tagln-Ager)#Yon)
|
abnormal vascular smooth muscle physiology
|
J:82620
|
abnormal vascular wound healing
|
J:82620
|
decreased vascular smooth muscle cell proliferation
|
J:82620
|
Tg(Tagln-tTA)1Mrab/0 Tg(tetO-Mcpt1)1Mrab/0
(involves: C57BL/6 * SJL)
|
abnormal vasoconstriction
|
J:70031
|
increased vasoconstriction
|
J:70031
|
Tg(Tek-tTA)1Rwng/0 Tg(tetO-Notch4*)1Rwng/0
(involves: FVB/N)
|
abnormal blood vessel physiology
|
J:139943
|
Tg(Thy1-APP)3Somm/0
(involves: C57BL/6J * DBA/2)
|
impaired blood-brain barrier function
|
J:67583
|
Tg(Tnf)6074Gkl/0
(involves: C57BL/6 * CBA)
|
impaired blood-brain barrier function
|
J:106592
|
Tgfatm1Unc/Tgfatm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
retina neovascularization
|
J:4605
|
Tgfb1tm1N/Tgfb1tm1N
(involves: 129S/SvEv)
|
phlebitis
|
J:50848
|
Tgfb1i1tm1.1Knos/Tgfb1i1tm1.1Knos
(involves: C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:223628
|
abnormal vascular wound healing
|
J:223628
|
Tgfbr2tm1Karl/Tgfbr2tm1Karl H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal blood vessel physiology
|
J:96359
|
abnormal vasodilation
|
J:96359
|
Timp1tm1Pds/Timp1tm1Pds
(involves: 129S4/SvJae * C57BL/6)
|
increased vascular permeability
|
J:112941
|
Timp3tm1Osya/Timp3tm1Osya
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal blood vessel physiology
|
J:211441
|
decreased vasodilation
|
J:211441
|
Timp3tm1Osya/Timp3tm1Osya
(B6.129P2-Timp3tm1Osya)
|
abnormal blood vessel physiology
|
J:193744
|
aortitis
|
J:193744
|
Tk1tm1Vnd/Tk1tm1Vnd
(involves: 129P2/OlaHsd * C57BL/6)
|
arteritis
|
J:101669
|
Tlr3tm1Aki/Tlr3tm1Aki
(involves: 129P2/OlaHsd)
|
abnormal vascular smooth muscle physiology
|
J:116310
|
Tlr3tm1Flv/Tlr3tm1Flv
(involves: 129S1/Sv * C57BL/6)
|
abnormal vascular wound healing
|
J:169238
|
Tlr4Lps-d/Tlr4Lps-d
(B6.C3-Tlr4Lps-d)
|
abnormal vascular wound healing
|
J:101995
|
Tnftm1Gkl/Tnftm1Gkl Zfp36tm1Pjb/Zfp36tm1Pjb
(involves: 129S/SvEv * C57BL/6)
|
abnormal vasodilation
|
J:214114
|
Tnfrsf19Gt(OST294987)Lex/Tnfrsf19Gt(OST294987)Lex
(involves: 129S5/SvEvBrd)
|
impaired blood-brain barrier function
|
J:181470
|
Tnfrsf21tm1Vmd/Tnfrsf21tm1Vmd
(Not Specified)
|
impaired blood-brain barrier function
|
J:181470
|
Trpc4tm1Bni/Trpc4tm1Bni
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))
|
decreased vasodilation
|
J:68178
|
Trpc6tm1Lbi/Trpc6tm1Lbi
(involves: 129S/SvEv * C57BL/6J)
|
abnormal vascular smooth muscle physiology
|
J:106082
|
abnormal vasoconstriction
|
J:106082
|
increased vasoconstriction
|
J:106082
|
Trpm4tm1.1Mfre/Trpm4tm1.1Mfre
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ)
|
increased vascular permeability
|
J:118679
|
Trpv4tm1Rck/Trpv4tm1Rck
(Not Specified)
|
abnormal vascular endothelial cell physiology
|
J:129365
|
abnormal vasodilation
|
J:129365
|
Tulp4tm1a(KOMP)Wtsi/Tulp4+
(involves: C57BL/6N * C57BL/6NRj)
|
telangiectasia
|
J:344151
|
Tusc2tm1Avi/Tusc2+
(involves: 129S1/Sv * C57BL/6J)
|
arteritis
|
J:119985
|
Tusc2tm1Avi/Tusc2tm1Avi
(involves: 129S1/Sv * C57BL/6J)
|
arteritis
|
J:119985
|
Tusc2tm1Avi/Tusc2tm1Avi
(involves: 129S1/Sv)
|
arteritis
|
J:309768
|
Ubac1em1(IMPC)J/Ubac1em1(IMPC)J
(C57BL/6NJ-Ubac1em1(IMPC)J/Mmjax)
|
cornea vascularization
|
J:211773
|
Uhmk1tm1Enbl/Uhmk1tm1Enbl
(involves: 129/Sv * C57BL/6)
|
abnormal vascular wound healing
|
J:144737
|
Uts2rtm1Djbe/Uts2rtm1Djbe
(B6.129P2-Uts2rtm1Djbe)
|
abnormal vasoconstriction
|
J:103118
|
Vav2tm1Tnr/Vav2tm1Tnr Vav3tm1Swat/Vav3tm1Swat
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
abnormal vascular endothelial cell physiology
|
J:110334
|
Vegfbtm1Gfk/Vegfbtm1Gfk
(involves: 129T2/SvEms)
|
cornea vascularization
|
J:114973
|
Vhltm1Jae/Vhltm1Jae Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA)
|
abnormal vasodilation
|
J:97652
|
Vhltm1Jae/Vhltm1Jae Tg(KRT14-cre)1Ipc/0
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
increased vascular permeability
|
J:144666
|
Vimtm1Cba/Vimtm1Cba
(involves: 129S2/SvPas)
|
abnormal vasoconstriction
|
J:43049
|
abnormal vasodilation
|
J:43049
|
Vldlrtm1Her/Vldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6)
|
choroidal neovascularization
|
J:114757
|
pathological neovascularization
|
J:114757
|
Vldlrtm1Her/Vldlrtm1Her
(B6;129S7-Vldlrtm1Her/J)
|
choroidal neovascularization
|
J:132497
|
retina neovascularization
|
J:132497,
J:128315
|
Vldlrtm1Lex/Vldlrtm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased vascular permeability
|
J:181399
|
retina neovascularization
|
J:181399
|
Vstm4em1Gypk/Vstm4em1Gypk
(involves: C57BL/6J)
|
abnormal induced retina neovascularization
|
J:285234
|
Vwftm1Wgr/Vwftm1Wgr
(B6.129S2-Vwftm1Wgr)
|
impaired blood-brain barrier function
|
J:140334
|
Zeb1tm2Yhi/Zeb1+
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vascular wound healing
|
J:110800
|
Zeb1tm2Yhi/Zeb1tm2Yhi
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vascular smooth muscle physiology
|
J:110800
|
Zfp36tm1Pjb/Zfp36tm1Pjb
(B6.Cg-Zfp36tm1Pjb)
|
abnormal vasodilation
|
J:214114
|
blood vessel inflammation
|
J:214114
|
Zfp185em1Cya/Y
(C57BL/6J-Zfp185em1Cya)
|
increased vascular permeability
|
J:345303
|
Zfyve21tm2c(EUCOMM)Wtsi/Zfyve21tm2c(EUCOMM)Wtsi Tg(Cdh5-cre/ERT2)1Rha/0 Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6N)
|
increased vascular permeability
|
J:350543
|